US20190351111A1 - Fluid storage devices, systems, and methods - Google Patents
Fluid storage devices, systems, and methods Download PDFInfo
- Publication number
- US20190351111A1 US20190351111A1 US16/528,441 US201916528441A US2019351111A1 US 20190351111 A1 US20190351111 A1 US 20190351111A1 US 201916528441 A US201916528441 A US 201916528441A US 2019351111 A1 US2019351111 A1 US 2019351111A1
- Authority
- US
- United States
- Prior art keywords
- interface
- storage
- dressing
- sealing member
- layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000003860 storage Methods 0.000 title claims abstract description 356
- 239000012530 fluid Substances 0.000 title claims abstract description 153
- 238000000034 method Methods 0.000 title claims abstract description 36
- 238000007789 sealing Methods 0.000 claims abstract description 144
- 230000002745 absorbent Effects 0.000 claims abstract description 76
- 239000002250 absorbent Substances 0.000 claims abstract description 76
- 238000004891 communication Methods 0.000 claims abstract description 71
- 239000000853 adhesive Substances 0.000 claims description 98
- 230000001070 adhesive effect Effects 0.000 claims description 98
- 239000000463 material Substances 0.000 claims description 81
- 239000007788 liquid Substances 0.000 claims description 40
- 230000002829 reductive effect Effects 0.000 claims description 23
- 230000001464 adherent effect Effects 0.000 claims description 18
- 238000000576 coating method Methods 0.000 claims description 17
- 239000011248 coating agent Substances 0.000 claims description 15
- 229920001296 polysiloxane Polymers 0.000 claims description 11
- 239000006260 foam Substances 0.000 claims description 9
- 239000000416 hydrocolloid Substances 0.000 claims description 6
- 210000001519 tissue Anatomy 0.000 description 128
- 229920001477 hydrophilic polymer Polymers 0.000 description 24
- 230000002209 hydrophobic effect Effects 0.000 description 24
- 239000004814 polyurethane Substances 0.000 description 19
- 210000002615 epidermis Anatomy 0.000 description 15
- 229920002635 polyurethane Polymers 0.000 description 15
- 239000000499 gel Substances 0.000 description 14
- 235000019645 odor Nutrition 0.000 description 10
- 229920006395 saturated elastomer Polymers 0.000 description 8
- 239000004599 antimicrobial Substances 0.000 description 7
- 229920000098 polyolefin Polymers 0.000 description 7
- 230000002708 enhancing effect Effects 0.000 description 6
- 230000000670 limiting effect Effects 0.000 description 6
- -1 polyethylene Polymers 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 230000008878 coupling Effects 0.000 description 5
- 238000010168 coupling process Methods 0.000 description 5
- 238000005859 coupling reaction Methods 0.000 description 5
- 239000004952 Polyamide Substances 0.000 description 4
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 4
- 239000003522 acrylic cement Substances 0.000 description 4
- 230000000845 anti-microbial effect Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 229920001971 elastomer Polymers 0.000 description 4
- 239000000017 hydrogel Substances 0.000 description 4
- 229920002647 polyamide Polymers 0.000 description 4
- 239000005060 rubber Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 229920006249 styrenic copolymer Polymers 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000003466 welding Methods 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 3
- 239000004721 Polyphenylene oxide Substances 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 229920006397 acrylic thermoplastic Polymers 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920000570 polyether Polymers 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920006126 semicrystalline polymer Polymers 0.000 description 3
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 229920002943 EPDM rubber Polymers 0.000 description 2
- 229920000181 Ethylene propylene rubber Polymers 0.000 description 2
- 244000043261 Hevea brasiliensis Species 0.000 description 2
- 229920000459 Nitrile rubber Polymers 0.000 description 2
- 239000005062 Polybutadiene Substances 0.000 description 2
- 229920002614 Polyether block amide Polymers 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- JEDYYFXHPAIBGR-UHFFFAOYSA-N butafenacil Chemical compound O=C1N(C)C(C(F)(F)F)=CC(=O)N1C1=CC=C(Cl)C(C(=O)OC(C)(C)C(=O)OCC=C)=C1 JEDYYFXHPAIBGR-UHFFFAOYSA-N 0.000 description 2
- 229920005549 butyl rubber Polymers 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000005266 casting Methods 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 230000009969 flowable effect Effects 0.000 description 2
- 229920002681 hypalon Polymers 0.000 description 2
- 229920003052 natural elastomer Polymers 0.000 description 2
- 229920001194 natural rubber Polymers 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 229920001084 poly(chloroprene) Polymers 0.000 description 2
- 229920002857 polybutadiene Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920001195 polyisoprene Polymers 0.000 description 2
- 229920001021 polysulfide Polymers 0.000 description 2
- 239000005077 polysulfide Substances 0.000 description 2
- 150000008117 polysulfides Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000013464 silicone adhesive Substances 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229920003048 styrene butadiene rubber Polymers 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000004433 Thermoplastic polyurethane Substances 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000003575 carbonaceous material Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 1
- 229920005570 flexible polymer Polymers 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 239000006261 foam material Substances 0.000 description 1
- 239000007792 gaseous phase Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229920001600 hydrophobic polymer Polymers 0.000 description 1
- 230000002706 hydrostatic effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 238000011176 pooling Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 239000004447 silicone coating Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/05—Bandages or dressings; Absorbent pads specially adapted for use with sub-pressure or over-pressure therapy, wound drainage or wound irrigation, e.g. for use with negative-pressure wound therapy [NPWT]
-
- A61M1/0088—
-
- A61F13/00068—
-
- A61F13/0216—
-
- A61M1/0003—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/64—Containers with integrated suction means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/91—Suction aspects of the dressing
- A61M1/915—Constructional details of the pressure distribution manifold
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/98—Containers specifically adapted for negative pressure wound therapy
- A61M1/984—Containers specifically adapted for negative pressure wound therapy portable on the body
- A61M1/985—Containers specifically adapted for negative pressure wound therapy portable on the body the dressing itself forming the collection container
Definitions
- an interface sealing member for treating a tissue site may include a liquid impermeable material and a receiving site.
- the liquid impermeable material may have an interior facing side and an exterior facing side positioned opposite the interior facing side.
- the liquid impermeable material may be adapted to cover the tissue site and to provide a sealed treatment space between the interior facing side of the liquid impermeable material and the tissue site.
- the receiving site may be positioned at the exterior facing side of the liquid impermeable material.
- the receiving site may comprise a non-adherent treatment.
- a method of treating a tissue site may include positioning an interface dressing on the tissue site and in fluid communication with the tissue site.
- the method may also include releaseably securing a storage dressing to the interface dressing and in fluid communication with the interface dressing; and applying reduced pressure to the storage dressing.
- the method may include extracting fluid from the tissue site through the interface dressing.
- the storage dressing may be in fluid communication with the tissue site through the interface dressing.
- the method may additionally include storing fluid extracted from the interface dressing within the storage dressing.
- FIG. 1C is detail view taken at reference FIG. 1C , depicted in FIG. 1A , illustrating the interface dressing of FIG. 1A positioned proximate to tissue surrounding the tissue site;
- FIG. 3 is a cut-away view of the storage dressing of FIGS. 1A and 2A ;
- the interface manifold 22 may be adapted to be positioned proximate to, adjacent, or at the tissue site 12 , such as, for example, by cutting or otherwise shaping the interface manifold 22 in any suitable manner to fit the tissue site 12 . Further, the interface manifold 22 may be adapted to be positioned in fluid communication with the tissue site 12 and may distribute reduced pressure to the tissue site 12 . In some embodiments, the interface manifold 22 may be positioned in direct contact with the tissue site 12 .
- the interface manifold 22 may be formed from any manifold material or flexible bolster material that provides a vacuum space, or treatment space, such as, for example, a porous and permeable foam or foam-like material, a member formed with pathways, a graft, or a gauze.
- the interface manifold 22 may be a reticulated, open-cell polyurethane or polyether foam that allows good permeability of fluids.
- One such foam material is the VAC® GranuFoam® material available from Kinetic Concepts, Inc. (KCI) of San Antonio, Tex.
- the interface manifold 22 may comprise a porous, hydrophobic material. The hydrophobic characteristics of the interface manifold 22 may prevent the interface manifold 22 from directly absorbing fluid, such as exudate, from the tissue site 12 , but allow the fluid to pass through.
- the interface sealing member 24 may be formed from any material that allows for a fluid seal.
- a fluid seal may be a seal adequate to maintain reduced pressure, if applicable, at a desired site.
- the interface sealing member 24 may comprise, for example, one or more of the following materials: hydrophilic polyurethane; cellulosics; hydrophilic polyamides; polyvinyl alcohol; polyvinyl pyrrolidone; hydrophilic acrylics; hydrophilic silicone elastomers; an INSPIRE 2301 material from Expopack Advanced Coatings of Wrexham, United Kingdom having, for example, a moisture vapor transmission rate or MVTR (inverted cup technique) of 14400 g/m 2 /24 hours and a thickness of about 30 microns; a thin, uncoated polymer drape; natural rubbers; polyisoprene; styrene butadiene rubber; chloroprene rubber; polybutadiene; nitrile rubber; butyl rubber; ethylene propylene rubber;
- an attachment device or interface layer adhesive 36 may be adapted to be positioned between the interface sealing member 24 and the tissue site 12 .
- the interface layer adhesive 36 may be positioned on or applied to the interior facing side 32 of the interface sealing member 24 for facing the tissue site 12 .
- the interface sealing member 24 may be sealed directly against tissue surrounding the tissue site 12 , such as the epidermis 14 , by the interface layer adhesive 36 .
- the interface layer adhesive 36 may seal the interface sealing member 24 against a gasket or drape adapted to be positioned between the interface layer adhesive 36 and the epidermis 14 .
- the interface layer adhesive 36 may be a medically-acceptable adhesive and may take numerous forms, such as an adhesive sealing tape, drape tape, paste, hydrocolloid, hydrogel, or other suitable sealing device.
- the interface layer adhesive 36 may also be flowable.
- the interface layer adhesive 36 may comprise, without limitation, an acrylic adhesive, rubber adhesive, high-tack silicone adhesive, polyurethane, or other adhesive substance.
- the interface layer adhesive 36 may be a pressure-sensitive adhesive comprising an acrylic adhesive with coat weight of 15 grams/m 2 (gsm) to 70 grams/m 2 (gsm).
- the pressure-sensitive adhesive may be applied on a side of the interface sealing member 24 adapted to face the epidermis 14 and the tissue site 12 , such as the interior facing side 32 of the interface sealing member 24 .
- the pressure-sensitive adhesive may provide a fluid seal between the interface sealing member 24 and the epidermis 14 , and may be utilized in combination with a gasket or drape against the epidermis 14 .
- the receiving site 26 may be positioned at or on the exterior facing side 34 of the interface sealing member 24 .
- a portion of the receiving site 26 may be adaptable for providing fluid communication between the exterior facing side 34 and the interior facing side 32 of the interface sealing member 24 .
- the receiving site 26 may be in fluid communication with the interface manifold 22 and the sealed treatment space 30 through a receiving site aperture 38 that may be disposed through the interface sealing member 24 .
- the non-adherent treatment 40 may comprise a coating of a non-adherent material including, without limitation, an olefinic coating, such as a polyethylene or wax; a fluorocarbon coating, such as a polytetrafluoroethylene (PTFE); a highly hydrophilic coating, such as a water soluble or swelling polymer that would retain a high level of moisture capable of reducing bond strength; a coating containing a plasticizer capable of reducing the tackiness of an acrylic or other adhesive; and an ultraviolet (UV) light sensitive coating capable of cross-linking and becoming brittle under the action of UV light.
- the substrate material of the interface sealing member 24 on the exterior facing side 34 may be treated or otherwise modified to have non-adherent properties.
- the interface base layer 28 may comprise, without limitation, a silicone gel, a soft silicone, hydrocolloid, hydrogel, polyurethane gel, polyolefin gel, hydrogenated styrenic copolymer gel, a foamed gel, a soft closed cell foam such as polyurethanes and polyolefins that may be coated with an adhesive, polyurethane, polyolefin, and hydrogenated styrenic copolymers.
- the interface base layer 28 may have a thickness between about 500 microns ( ⁇ m) and about 1000 microns ( ⁇ m).
- the interface base layer 28 may have a stiffness between about 5 Shore OO to about 80 Shore OO.
- the interface base layer 28 may be comprised of hydrophobic or hydrophilic materials.
- the interface base layer 28 may be an interface base layer 28 a . Similar to the interface sealing member 24 , the interface base layer 28 a may be adapted to cover the tissue site 12 . A portion of the interface base layer 28 a may be adapted to overlap tissue surrounding the tissue site 12 , such as the epidermis 14 , or otherwise surround the tissue site 12 .
- the interface base layer 28 a may include a plurality of interface layer apertures 42 disposed through opposing sides of the interface base layer 28 a .
- the interface layer apertures 42 may be adapted to be in fluid communication with the sealed treatment space 30 , the interface manifold 22 , and tissue surrounding the tissue site 12 , such as the epidermis 14 .
- the interface layer adhesive 36 may be positioned between the interface sealing member 24 and the interface base layer 28 a in fluid communication with tissue surrounding the tissue site 12 through the interface layer apertures 42 .
- the interface layer apertures 42 in the interface base layer 28 a may have any shape, such as, for example, circles, squares, stars, ovals, polygons, slits, complex curves, rectilinear shapes, triangles, or other shapes.
- the interface layer apertures 42 may be formed by cutting, by application of local RF energy, or other suitable techniques for forming an opening.
- the interface layer apertures 42 may have a diameter between about 6 millimeters to about 50 millimeters. Further, the interface layer apertures 42 may be uniformly distributed or randomly distributed on the interface base layer 28 a.
- the interface base layer 28 may be an interface base layer 28 b .
- the interface base layer 28 b may be, for example, formed in the shape of a ring or any other suitable shape for surrounding the tissue site 12 . While reference is made to a “ring,” discrete members, including linear members, may make up the interface base layer 28 b in any suitable manner.
- a ring-like or other suitable shape for the interface base layer 28 b may save costs by reducing or eliminating material covering the tissue site 12 while still enhancing the fluid seal around the tissue site 12 .
- tissue surrounding the tissue site 12 such as the epidermis 14 , may have recesses, cracks, wrinkles, or other discontinuities that may cause leaks.
- folds, buckles, wrinkles, or other discontinuities may form in the interface sealing member 24 and cause leaks.
- the interface base layer 28 b may reduce any leakage caused by such discontinuities around the tissue site 12 .
- the interface base layer 28 b may be formed, as an illustrative example, by applying or bonding a continuous or discontinuous ring of any of the materials recited above for the interface base layer 28 around the tissue site 12 or to a portion of the interior facing side 32 of the interface sealing member 24 for positioning between the interface sealing member 24 and tissue surrounding the tissue site 12 .
- the interface base layer 28 b may be coupled directly to the interface sealing member 24 and tissue surrounding the tissue site 12 , or by the interface layer adhesive 36 described above.
- the interface base layer 28 b may comprise, without limitation, hydrocolloids; hydrogels; silicone polymers; crosslinked and uncrosslinked gels; and natural gums such as xanthan, guar, and cellulose.
- the interface base layer 28 b may include other soft polymer gels, such as, for example, those based on polyurethanes, polyolefin gels, and acrylics.
- the absorbent in the interface base layer 28 b may wick or draw fluid in a lateral direction within the interface dressing 20 b , normal to the thickness of the interface dressing 20 b , and toward the lateral edges of the interface dressing 20 b for absorption in the interface base layer 28 b.
- the system 10 may include a second dressing or storage dressing 124 , and a reduced-pressure source 128 .
- the storage dressing 124 may be positioned in fluid communication with the interface dressing 20 at, for example, the receiving site 26 of the interface sealing member 24 .
- the storage dressing 124 may be adapted to provide reduced pressure from the reduced-pressure source 128 to the interface manifold 22 , and to store fluid extracted from the tissue site 12 through the interface manifold 22 .
- reduced pressure may not be applied, and fluid may be extracted from the tissue site 12 into the storage dressing 124 by wicking action.
- the storage layer apertures 160 in the storage base layer 132 may have any shape, such as, for example, circles, squares, stars, ovals, polygons, slits, complex curves, rectilinear shapes, triangles, or other shapes.
- the storage layer apertures 160 may be formed by cutting, by application of local RF energy, or other suitable techniques for forming an opening.
- each of the storage layer apertures 160 of the plurality of storage layer apertures 160 may be substantially circular in shape, having a diameter and an area.
- the area of each of the storage layer apertures 160 may refer to an open space or open area defining each of the storage layer apertures 160 .
- the diameter of each of the storage layer apertures 160 may define the area of each of the storage layer apertures 160 .
- the area of one of the storage layer apertures 160 may be defined by multiplying the square of half the diameter of the storage layer aperture 160 by the value 3.14.
- each of the storage layer apertures 160 a may be separated from one another by a distance A between about 2.8 millimeters to about 3.2 millimeters. Further, the diameter of at least one of the storage layer apertures 160 a may be separated from the diameter of at least one of the storage layer apertures 160 b by the distance A. The diameter of each of the storage layer apertures 160 b may also be separated from one another by the distance A. A center of one of the storage layer apertures 160 c may be separated from a center of another of the storage layer apertures 160 c in a first direction by a distance B between about 2.8 millimeters to about 3.2 millimeters.
- At least one of the storage layer apertures 160 a in the periphery 152 of the storage base layer 132 may be positioned at the edges 159 of the periphery 152 and may have an interior cut open or exposed at the edges 159 that is in fluid communication in a lateral direction with the edges 159 .
- the lateral direction may refer to a direction toward the edges 159 and in the same plane as the storage base layer 132 .
- a plurality of the storage layer apertures 160 a in the periphery 152 may be positioned proximate to or at the edges 159 and in fluid communication in a lateral direction with the edges 159 .
- the storage layer apertures 160 b at the corners 158 of the periphery 152 may be smaller than the storage layer apertures 160 a in other portions of the periphery 152 as described above.
- the smaller size of the storage layer apertures 160 b compared to the storage layer apertures 160 a may maximize the surface area of the storage layer adhesive 136 exposed and in fluid communication through the storage layer apertures 160 b at the corners 158 .
- the edges 159 may intersect at substantially a right angle, or about 90 degrees, to define the corners 158 .
- the corners 158 may have a radius of about 10 millimeters.
- the storage layer apertures 160 b at the corners 158 being fully housed within the storage base layer 132 may substantially preclude fluid communication of the storage layer adhesive 136 exterior to the corners 159 , and may provide improved handling of the storage dressing 124 during deployment. Further, the exterior of the corners 158 being substantially free of the storage layer adhesive 136 may increase the flexibility of the corners 158 to enhance comfort.
- any of the storage layer apertures 160 may be adjusted in size and number to maximize the surface area of the storage layer adhesive 136 in fluid communication through the storage layer apertures 160 for a particular application or geometry of the storage base layer 132 .
- the storage layer apertures 160 b may be positioned in the periphery 152 and at the border 161 .
- the storage layer apertures 160 b , or apertures of another size may be positioned as described above in other locations of the storage base layer 132 that may have a complex geometry or shape.
- the storage layer adhesive 136 may be a medically-acceptable adhesive.
- the storage layer adhesive 136 may also be flowable.
- the storage layer adhesive 136 may comprise an acrylic adhesive, rubber adhesive, high-tack silicone adhesive, polyurethane, or other adhesive substance.
- the storage layer adhesive 136 may be a pressure-sensitive adhesive comprising an acrylic adhesive with coat weight of 15 grams/m 2 (gsm) to 70 grams/m 2 (gsm).
- the storage layer adhesive 136 may be a layer having substantially the same shape as the periphery 152 of the storage base layer 132 as shown in FIG. 4A .
- the storage layer adhesive 136 may be a continuous or discontinuous layer.
- Factors that may be utilized to control the adhesion strength of the storage dressing 124 may include the diameter and number of the storage apertures 160 in the storage base layer 132 , the thickness of the storage base layer 132 , the thickness and amount of the storage layer adhesive 136 , and the tackiness of the storage layer adhesive 136 .
- An increase in the amount of the storage layer adhesive 136 extending through the storage layer apertures 160 may correspond to an increase in the adhesion strength of the storage dressing 124 .
- a decrease in the thickness of the storage base layer 132 may correspond to an increase in the amount of the storage layer adhesive 136 extending through the storage layer apertures 160 .
- a release liner 162 may be attached to or positioned adjacent to the storage base layer 132 to protect the storage layer adhesive 136 prior to application of the storage dressing 124 to the receiving site 26 .
- the storage base layer 132 Prior to application of the storage dressing 124 , the storage base layer 132 may be positioned between the storage sealing member 140 and the release liner 162 . Removal of the release liner 162 may expose the storage base layer 132 and the storage layer adhesive 136 for application of the storage dressing 124 to the receiving site 26 .
- the release liner 162 may also provide stiffness to assist with deployment of the storage dressing 124 .
- the release liner 162 may be, for example, a casting paper, a film, or polyethylene. Further, the release liner 162 may be a polyester material such as polyethylene terephthalate (PET), or similar polar semi-crystalline polymer.
- PET polyethylene terephthalate
- the use of a polar semi-crystalline polymer for the release liner 162 may substantially preclude wrinkling or other deformation of the storage dressing 124 .
- the polar semi-crystalline polymer may be highly orientated and resistant to softening, swelling, or other deformation that may occur when brought into contact with components of the storage dressing 124 , or when subjected to temperature or environmental variations, or sterilization.
- a release agent may be disposed on a side of the release liner 162 that is configured to contact the storage base layer 132 .
- the release agent may be a silicone coating and may have a release factor suitable to facilitate removal of the release liner 162 by hand and without damaging or deforming the storage dressing 124 .
- the release agent may be flourosilicone.
- the release liner 162 may be uncoated or otherwise used without a release agent.
- the storage sealing member 140 may cover the receiving site 26 and the receiving site aperture 38 to provide a fluid seal and a sealed storage space 174 between the receiving site 26 and the storage sealing member 140 .
- the storage base layer 132 may be positioned between the storage sealing member 140 and the receiving site 26 of the interface sealing member 24 .
- the sealed storage space 174 may be in fluid communication with the sealed treatment space 30 through the receiving site aperture 38 , for example. Further, the enclosure 172 may provide a portion of the sealed storage space 174 when the storage sealing member 140 is positioned at the receiving site 26 as described.
- a peripheral portion 186 of the first wicking layer 176 may be coupled to a peripheral portion 187 of the second wicking layer 180 to define a wicking layer enclosure 188 between the first wicking layer 176 and the second wicking layer 180 .
- the wicking layer enclosure 188 may surround or otherwise encapsulate the absorbent layer 184 between the first wicking layer 176 and the second wicking layer 180 .
- the fluid management assembly 144 may include, without limitation, any number of wicking layers and absorbent layers as desired for treating a particular tissue site.
- the absorbent layer 184 may be a plurality of absorbent layers 184 positioned in fluid communication between the first wicking layer 176 and the second wicking layer 180 as described above.
- at least one intermediate wicking layer 189 may be disposed in fluid communication between the plurality of absorbent layers 184 .
- the plurality of absorbent layers 184 and the at least one intermediate wicking layer 189 may be positioned within the wicking layer enclosure 188 .
- the absorbent layer 184 may be a hydrophilic material adapted to absorb fluid from, for example, the tissue site 12 .
- Materials suitable for the absorbent layer 184 may include Luquafleece® material, Texsus FP2326, BASF 402C, Technical Absorbents 2317 available from Technical Absorbents (www.techabsorbents.com), sodium polyacrylate super absorbers, cellulosics (carboxy methyl cellulose and salts such as sodium CMC), or alginates.
- Materials suitable for the first wicking layer 176 and the second wicking layer 180 may include any material having a grain structure capable of wicking fluid as described herein, such as, for example, Libeltex TDL2 80 gsm.
- the fluid management assembly 144 may be a pre-laminated structure manufactured at a single location or individual layers of material stacked upon one another as described above. Individual layers of the fluid management assembly 144 may be bonded or otherwise secured to one another without adversely affecting fluid management by, for example, utilizing a solvent or non-solvent adhesive, or by thermal welding. Further, the fluid management assembly 144 may be coupled to the border 161 of the base layer 132 in any suitable manner, such as, for example, by a weld or an adhesive. The border 161 being free of the apertures 160 as described above may provide a flexible barrier between the fluid management assembly 144 and the tissue site 104 for enhancing comfort.
- the conduit interface 148 may comprise a medical-grade, soft polymer or other pliable material.
- the conduit interface 148 may be formed from polyurethane, polyethylene, polyvinyl chloride (PVC), fluorosilicone, or ethylene-propylene, etc.
- the conduit interface 148 may be molded from DEHP-free PVC.
- the conduit interface 148 may be formed in any suitable manner such as by molding, casting, machining, or extruding. Further, the conduit interface 148 may be formed as an integral unit or as individual components and may be coupled to the storage dressing 124 by, for example, adhesive or welding.
- the conduit interface 148 may be formed of an absorbent material having absorbent and evaporative properties.
- the absorbent material may be vapor permeable and liquid impermeable, thereby being configured to permit vapor to be absorbed into and evaporated from the material through permeation while inhibiting permeation of liquids.
- the absorbent material may be, for example, a hydrophilic polymer such as a hydrophilic polyurethane. Although the term hydrophilic polymer may be used in the illustrative embodiments that follow, any absorbent material having the properties described herein may be suitable. Further, the absorbent material or hydrophilic polymer may be suitable for use in various components of the system 10 as described herein.
- hydrophilic polymer for the conduit interface 148 may permit liquids in the conduit interface 148 to evaporate, or otherwise dissipate, during operation.
- the hydrophilic polymer may allow the liquid to permeate or pass through the conduit interface 148 as vapor, in a gaseous phase, and evaporate into the atmosphere external to the conduit interface 148 .
- Such liquids may be, for example, condensate or other liquids. Condensate may form, for example, as a result of a decrease in temperature within the conduit interface 148 , or other components of the system 10 , relative to the temperature at the tissue site 12 . Removal or dissipation of liquids from the conduit interface 148 may increase visual appeal and prevent odor. Further, such removal of liquids may also increase efficiency and reliability by reducing blockages and other interference with the components of the system 10 .
- the hydrophilic polymer and the components of the system 10 incorporating the hydrophilic polymer may also have a size that is substantially the same in both the unsaturated state and the saturated state. Further, the hydrophilic polymer may remain dry, cool to the touch, and pneumatically sealed in the saturated state and the unsaturated state. The hydrophilic polymer may also remain substantially the same color in the saturated state and the unsaturated state. In this manner, this hydrophilic polymer may retain sufficient strength and other physical properties to remain suitable for use in the system 10 .
- An example of such a hydrophilic polymer is offered under the trade name Techophilic HP-93A-100, available from The Lubrizol Corporation of Wickliffe, Ohio, United States. Techophilic HP-93A-100 is an absorbent hydrophilic thermoplastic polyurethane capable of absorbing 100% of the unsaturated mass of the polyurethane in water and having a durometer or Shore Hardness of about 83 Shore A.
- the odor filter 194 and the primary hydrophobic filter 195 may be positioned in any exit location in the storage dressing 124 that is in fluid communication with the atmosphere or the reduced-pressure source 128 .
- the odor filter 194 may also be positioned in any suitable location in the system 10 that is in fluid communication with the tissue site 12 .
- the reduced-pressure source 128 may provide reduced pressure as part of the system 10 .
- the reduced-pressure source 128 may be positioned in fluid communication with the interface manifold 22 .
- the reduce-pressure source 128 may be in fluid communication with the interface manifold 22 through at least the absorbent layer 184 .
- the reduced-pressure source 128 may be any suitable device for providing reduced pressure, such as, for example, a vacuum pump, wall suction, hand pump, or other source.
- reduced pressure may refer to a pressure less than the ambient pressure at a tissue site being subjected to treatment. In some embodiments, the reduced pressure may be less than the atmospheric pressure. The reduced pressure may also be less than a hydrostatic pressure at a tissue site. Unless otherwise indicated, values of pressure stated herein are gauge pressures. While the amount and nature of reduced pressure applied to a tissue site may vary according to the application, in some embodiments, the reduced pressure may be between about ⁇ 5 mm Hg to about ⁇ 500 mm Hg. In other embodiments, the reduced pressure may be between about ⁇ 100 mm Hg to about ⁇ 200 mm Hg.
- a conduit 196 having an internal lumen 197 may be coupled in fluid communication between the reduced-pressure source 128 and the storage dressing 124 .
- the internal lumen 197 may have an internal diameter between about 0.5 millimeters to about 3.0 millimeters. In some embodiments, the internal diameter of the internal lumen 197 may be between about 1 millimeter to about 2 millimeters.
- the conduit interface 148 may be coupled in fluid communication with the storage dressing 124 and adapted to connect between the conduit 196 and the storage dressing 124 for providing fluid communication with the reduced-pressure source 128 .
- the conduit interface 148 may be fluidly coupled to the conduit 196 in any suitable manner, such as, for example, by an adhesive, solvent or non-solvent bonding, welding, or interference fit.
- the aperture 170 in the storage sealing member 140 may provide fluid communication between the storage dressing 124 and the conduit interface 148 .
- the conduit interface 148 may be in fluid communication with the enclosure 172 and the sealed storage space 174 through the aperture 170 in the storage sealing member 140 .
- the conduit 196 may be inserted into the storage dressing 124 through the aperture 170 in the storage sealing member 140 to provide fluid communication with the reduced-pressure source 128 without use of the conduit interface 148 .
- the reduced-pressure source 128 may also be directly coupled in fluid communication with the storage dressing 124 or the storage sealing member 140 without use of the conduit 196 .
- the conduit 196 may be, for example, a flexible polymer tube.
- a distal end of the conduit 196 may include a coupling 198 for attachment to the reduced-pressure source 128 .
- the conduit 196 may have a secondary hydrophobic filter 199 disposed in the internal lumen 197 such that fluid communication between the reduced-pressure source 128 and the storage dressing 124 is provided through the secondary hydrophobic filter 199 .
- the secondary hydrophobic filter 199 may be, for example, a porous, sintered polymer cylinder sized to fit the dimensions of the internal lumen 197 to substantially preclude liquid from bypassing the cylinder.
- the secondary hydrophobic filter 199 may also be treated with an absorbent material adapted to swell when brought into contact with liquid to block the flow of the liquid.
- the secondary hydrophobic filter 199 may be positioned at any location within the internal lumen 197 . However, positioning the secondary hydrophobic filter 199 within the internal lumen 197 closer toward the reduced-pressure source 128 , rather than the storage dressing 124 , may allow a user to detect the presence of liquid in the internal lumen 197 .
- the conduit 196 and the coupling 198 may be formed of an absorbent material or a hydrophilic polymer as described above for the conduit interface 148 . In this manner, the conduit 196 and the coupling 198 may permit liquids in the conduit 196 and the coupling 198 to evaporate, or otherwise dissipate, as described above for the conduit interface 148 .
- the conduit 196 and the coupling 198 may be, for example, molded from the hydrophilic polymer separately, as individual components, or together as an integral component. Further, a wall of the conduit 196 defining the internal lumen 197 may be extruded from the hydrophilic polymer.
- the conduit 196 may be less than about 1 meter in length, but may have any length to suit a particular application.
- a length of about 1 foot or 304.8 millimeters may provide enough absorbent and evaporative surface area to suit many applications, and may provide a cost savings compared to longer lengths. If an application requires additional length for the conduit 196 , the absorbent hydrophilic polymer may be coupled in fluid communication with a length of conduit formed of a non-absorbent hydrophobic polymer to provide additional cost savings.
- the interface manifold 22 may be disposed against or proximate to the tissue site 12 .
- the interior facing side 32 of the interface sealing member 24 may be positioned to cover the interface manifold 22 at the tissue site 12 and tissue surrounding the tissue site 12 .
- the interface base layer 28 and/or the interface layer adhesive 36 may be configured and positioned as described above for providing the sealed treatment space 30 between the interface sealing member 24 and the tissue site 12 .
- the receiving site aperture 38 may be cut through the interface sealing member 24 , the interface base layer 28 , and the interface layer adhesive 36 as applicable and in any suitable manner for providing fluid communication between the receiving site 26 and the interface manifold 22 .
- the storage dressing 124 may be applied over the receiving site 26 of the interface dressing 20 and about the receiving site aperture 38 to form the sealed storage space 174 .
- the storage base layer 132 may be applied covering the receiving site aperture 38 and a portion of the receiving site 26 surrounding the receiving site aperture 38 .
- the configuration of the storage dressing 124 described above may provide a reliable seal against the receiving site 26 while permitting removal and repositioning of the storage dressing 124 on the interface dressing 20 without damaging the interface sealing member 24 .
- the non-adherent treatment 40 at the receiving site 26 may further enhance the ability of a user to reposition or remove the storage dressing 124 for replacement.
- the fluid may move through the storage layer apertures 160 toward the fluid management assembly 144 in the storage dressing 124 .
- the fluid management assembly 144 may wick or otherwise move the fluid through the interface manifold 22 and away from the tissue site 12 .
- the interface manifold 22 may be adapted to communicate fluid from the tissue site 12 rather than store the fluid.
- the fluid management assembly 144 may be more absorbent than the interface manifold 22 .
- the fluid management assembly 144 being more absorbent than the interface manifold 22 may provide an absorbent gradient that may attract fluid from the tissue site 12 or the interface manifold 22 to the fluid management assembly 144 .
- the fluid management assembly 144 may be adapted to wick, pull, draw, or otherwise attract fluid from the tissue site 12 through the interface manifold 22 .
- the fluid may initially come into contact with the first wicking layer 176 .
- the first wicking layer 176 may distribute the fluid laterally along the surface of the first wicking layer 176 as described above for absorption and storage within the absorbent layer 184 .
- fluid coming into contact with the second wicking layer 180 may be distributed laterally along the surface of the second wicking layer 180 for absorption within the absorbent layer 184 .
- the storage dressing 124 may be a first storage dressing and the method may further include removing the first storage dressing from the interface dressing 20 ; and replacing the first storage dressing with a second storage dressing.
- the second storage dressing may be releaseably secured to the interface dressing 20 in fluid communication with the interface dressing 20 after removing the first storage dressing.
- removing the first storage dressing from the interface dressing 20 may occur after the first storage dressing is substantially full of fluid.
- the storage dressing 124 may include the absorbent layer 184 and the storage sealing member 140 .
- the method may further include: positioning the absorbent layer 184 on the exterior facing side 34 of the interface dressing 20 ; and covering the absorbent layer 184 with the storage sealing member 140 to provide the sealed storage space 174 between the storage sealing member 140 and the exterior facing side 34 of the interface dressing 20 .
- the storage dressing 124 may include the absorbent layer 184 and the storage sealing member 140 .
- the method may further include: positioning the absorbent layer 184 on the exterior facing side 34 of the interface sealing member 24 in fluid communication with the aperture 38 in the interface sealing member 24 ; and covering the absorbent layer 184 with the storage sealing member 140 to provide the sealed storage space 174 between the storage sealing member 140 and the exterior facing side 34 of the interface sealing member 24 .
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Vascular Medicine (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
- This application is a divisional of U.S. patent application Ser. No. 15/307,472, filed Oct. 28, 2016, which claims priority to International Application No. PCT/US2015/029037, filed May 4, 2015, which claims priority to U.S. Provisional Patent Application No. 61/988,076, entitled “Fluid Storage Devices, Systems, and Methods,” filed May 2, 2014, which are incorporated by reference in their entirety.
- This disclosure relates generally to medical treatment systems and, more particularly, but not by way of limitation, to dressings, systems, and methods for treating a tissue site.
- Depending on the medical circumstances, reduced pressure may be used for, among other things, reduced-pressure therapy to encourage granulation at a tissue site, draining fluids at a tissue site, closing a wound, reducing edema, promoting perfusion, and fluid management. Some dressings, systems, and methods may include a canister or container positioned separate from a dressing for storing fluids drained or extracted from a tissue site for disposal. These containers are often bulky and cumbersome for a patient being treated, and may be prone to leaks and spills. Some dressings, systems, and methods may require frequent replacement of a dressing or other component applied to the skin of a patient, causing the patient irritation or discomfort. Improvements to dressings, systems, and methods that may, without limitation, enhance fluid management for increasing comfort, fluid capacity, ease of use, and the useable life of the dressing and system are desirable.
- Shortcomings with certain aspects of tissue treatment devices, systems, and methods are addressed as shown and described in a variety of illustrative, non-limiting embodiments herein.
- In some embodiments, a system for treating a tissue site may include an interface manifold, an interface sealing member, a receiving site, an absorbent layer, and a storage sealing member. The interface manifold may be adapted to be positioned at the tissue site and to provide fluid communication with the tissue site. The interface sealing member may have an interior facing side and an exterior facing side. The interface sealing member may be adapted to provide a sealed treatment space between the interior facing side of the interface sealing member and the tissue site. The interface manifold may be sized for positioning in the sealed treatment space. The receiving site may be positioned at the exterior facing side of the interface sealing member. The absorbent layer may be for positioning at the receiving site. The storage sealing member may be adapted to provide a sealed storage space between the storage sealing member and the receiving site. The absorbent layer may be sized for positioning in the sealed storage space.
- In some embodiments, an interface sealing member for treating a tissue site may include a liquid impermeable material and a receiving site. The liquid impermeable material may have an interior facing side and an exterior facing side positioned opposite the interior facing side. The liquid impermeable material may be adapted to cover the tissue site and to provide a sealed treatment space between the interior facing side of the liquid impermeable material and the tissue site. The receiving site may be positioned at the exterior facing side of the liquid impermeable material. The receiving site may comprise a non-adherent treatment.
- In some embodiments, a method of treating a tissue site may include positioning an interface dressing on the tissue site and in fluid communication with the tissue site. The method may also include releaseably securing a storage dressing to the interface dressing and in fluid communication with the interface dressing; and applying reduced pressure to the storage dressing. Further, the method may include extracting fluid from the tissue site through the interface dressing. The storage dressing may be in fluid communication with the tissue site through the interface dressing. The method may additionally include storing fluid extracted from the interface dressing within the storage dressing.
- Other aspects, features, and advantages of the illustrative embodiments will become apparent with reference to the drawings and detailed description that follow.
-
FIG. 1A is a cut-away view of an illustrative embodiment of a system for treating a tissue site depicting an illustrative embodiment of an interface dressing and a storage dressing deployed at the tissue site; -
FIG. 1B is an exploded, perspective view of an illustrative embodiment of an interface sealing member depicted inFIG. 1A ; -
FIG. 1C is detail view taken at referenceFIG. 1C , depicted inFIG. 1A , illustrating the interface dressing ofFIG. 1A positioned proximate to tissue surrounding the tissue site; -
FIG. 2A is a cut-away view of another illustrative embodiment of a system for treating a tissue site depicting another illustrative embodiment of an interface dressing and a storage dressing deployed at the tissue site; -
FIG. 2B is an exploded, perspective view of another illustrative embodiment of an interface sealing member depicted inFIG. 2A ; -
FIG. 3 is a cut-away view of the storage dressing ofFIGS. 1A and 2A ; -
FIG. 4A is an exploded, perspective view of the storage dressing ofFIG. 3 , depicted without a conduit interface and with an illustrative embodiment of a release liner for protecting the storage dressing prior to application at a tissue site; -
FIG. 4B is a plan view of an illustrative embodiment of a base layer depicted in the storage dressing ofFIG. 4A ; -
FIG. 5 is a cut-away view of an illustrative embodiment of a fluid management assembly according to the storage dressing ofFIG. 3 ; -
FIG. 6 is a cut-away view of another illustrative embodiment of a fluid management assembly according to the storage dressing ofFIG. 3 ; and -
FIG. 7 is a cut-away view of an illustrative embodiment of a conduit interface depicted in the storage dressing ofFIG. 3 . - In the following detailed description of non-limiting, illustrative embodiments, reference is made to the accompanying drawings that form a part hereof. Other embodiments may be utilized, and logical, structural, mechanical, electrical, and chemical changes may be made without departing from the scope of the appended claims. To avoid detail not necessary to enable those skilled in the art to practice the embodiments described herein, the description may omit certain information known to those skilled in the art. The following detailed description is non-limiting, and the scope of the illustrative embodiments are defined by the appended claims. As used herein, unless otherwise indicated, “or” does not require mutual exclusivity.
- Referring to the drawings,
FIG. 1A depicts an illustrative embodiment of asystem 10 a for treating atissue site 12 of a patient.FIG. 2A depicts another illustrative embodiment of asystem 10 b for treating thetissue site 12. Thesystem 10 a and thesystem 10 b may be referred to collectively as a system 10 for treating thetissue site 12. Thetissue site 12 may extend through or otherwise involve anepidermis 14, adermis 16, and asubcutaneous tissue 18. Thetissue site 12 may be a sub-surface tissue site as depicted inFIGS. 1A and 2A that extends below the surface of theepidermis 14. Further, thetissue site 12 may be a surface tissue site (not shown) that predominantly resides on the surface of theepidermis 14, such as, for example, an incision. The system 10 may provide therapy to, for example, theepidermis 14, thedermis 16, and thesubcutaneous tissue 18, regardless of the positioning of the system 10 or the type of tissue site. - The system 10 may also be utilized without limitation at other tissue sites. For example, the
tissue site 12 may be, without limitation, the bodily tissue of any human, animal, or other organism, including bone tissue, adipose tissue, muscle tissue, dermal tissue, vascular tissue, connective tissue, cartilage, tendons, ligaments, or any other tissue. The treatment oftissue site 12 may include removal of fluids, such as exudate or ascites. - Referring to the embodiment of
FIG. 1A , thesystem 10 a may include a first dressing or interface dressing 20 a. Referring to the embodiment ofFIG. 2A , thesystem 10 b may include a first dressing or interface dressing 20 b. The interface dressing 20 a and 20 b may be referred to collectively as the interface dressing 20. The interface dressing 20 may include a tissue interface orinterface manifold 22 and aninterface sealing member 24. In some embodiments, the interface dressing 20 may include a receivingsite 26 and an interface base layer 28. - Referring generally to
FIGS. 1A-2B , theinterface manifold 22 may be adapted to be positioned proximate to, adjacent, or at thetissue site 12, such as, for example, by cutting or otherwise shaping theinterface manifold 22 in any suitable manner to fit thetissue site 12. Further, theinterface manifold 22 may be adapted to be positioned in fluid communication with thetissue site 12 and may distribute reduced pressure to thetissue site 12. In some embodiments, theinterface manifold 22 may be positioned in direct contact with thetissue site 12. - The
interface manifold 22 may be formed from any manifold material or flexible bolster material that provides a vacuum space, or treatment space, such as, for example, a porous and permeable foam or foam-like material, a member formed with pathways, a graft, or a gauze. In some embodiments, theinterface manifold 22 may be a reticulated, open-cell polyurethane or polyether foam that allows good permeability of fluids. One such foam material is the VAC® GranuFoam® material available from Kinetic Concepts, Inc. (KCI) of San Antonio, Tex. In some embodiments, theinterface manifold 22 may comprise a porous, hydrophobic material. The hydrophobic characteristics of theinterface manifold 22 may prevent theinterface manifold 22 from directly absorbing fluid, such as exudate, from thetissue site 12, but allow the fluid to pass through. - A material with a higher or lower density than GranuFoam® material may be desirable for the
interface manifold 22 depending on the application. Among the many possible materials, the following may be used without limitation: GranuFoam® material, Foamex® technical foam (www.foamex.com), a molded bed of nails structure, a patterned grid material such as those manufactured by Sercol Industrial Fabrics, 3D textiles such as those manufactured by Baltex of Derby, U.K., a gauze, a flexible channel-containing member, and a graft. - In some embodiments, any material or combination of materials may be used as a manifold material for the
interface manifold 22 provided that the manifold material is operable to distribute or collect fluid. For example, the term manifold may refer to a substance or structure capable of delivering fluids to or removing fluids from a tissue site through a plurality of pores, pathways, or flow channels. The plurality of pores, pathways, or flow channels may be interconnected to improve distribution of fluids provided to and removed from an area around the manifold. Examples of such manifolds may include, without limitation, devices that have structural elements arranged to form flow channels, cellular foam, such as open-cell foam, porous tissue collections, and liquids, gels, and foams that include or cure to include flow channels. In some embodiments, theinterface manifold 22 may be enhanced with ionic silver and anti-microbial agents. - The
interface sealing member 24 may be adapted to cover thetissue site 12 and to provide a fluid seal and a sealedtreatment space 30 relative to thetissue site 12. A portion of theinterface sealing member 24 may overlap tissue surrounding thetissue site 12, such as theepidermis 14. Theinterface manifold 22 may be sized or otherwise adapted to be positioned in the sealedtreatment space 30. For example, theinterface sealing member 24 may include an interior facingside 32 and anexterior facing side 34 positioned opposite theinterior facing side 32. The sealedtreatment space 30 may be provided between the interior facingside 32 of theinterface sealing member 24 and thetissue site 12. In some embodiments, theinterface sealing member 24 may comprise a liquid impermeable material adapted to cover thetissue site 12 and tissue surrounding thetissue site 12. - The
interface sealing member 24 may be formed from any material that allows for a fluid seal. A fluid seal may be a seal adequate to maintain reduced pressure, if applicable, at a desired site. Theinterface sealing member 24 may comprise, for example, one or more of the following materials: hydrophilic polyurethane; cellulosics; hydrophilic polyamides; polyvinyl alcohol; polyvinyl pyrrolidone; hydrophilic acrylics; hydrophilic silicone elastomers; an INSPIRE 2301 material from Expopack Advanced Coatings of Wrexham, United Kingdom having, for example, a moisture vapor transmission rate or MVTR (inverted cup technique) of 14400 g/m2/24 hours and a thickness of about 30 microns; a thin, uncoated polymer drape; natural rubbers; polyisoprene; styrene butadiene rubber; chloroprene rubber; polybutadiene; nitrile rubber; butyl rubber; ethylene propylene rubber; ethylene propylene diene monomer; chlorosulfonated polyethylene; polysulfide rubber; polyurethane (PU); EVA film; co-polyester; silicones; a silicone drape; a 3M Tegaderm® drape; a polyurethane (PU) drape such as one available from Avery Dennison Corporation of Pasadena, Calif.; polyether block polyamide copolymer (PEBAX), for example, from Arkema, France; Expopack 2327; or other appropriate material. - The
interface sealing member 24 may be vapor permeable and liquid impermeable, thereby allowing vapor and inhibiting liquids from exiting the sealedtreatment space 30 provided by the interface dressing 20. In some embodiments, theinterface sealing member 24 may be a flexible, breathable film, membrane, or sheet having a high MVTR of, for example, at least about 300 g/m2 per 24 hours. The use of a high MVTR material for theinterface sealing member 24 may permit moisture vapor to pass through theinterface sealing member 24, external to the interface dressing 20, while maintaining the fluid seal described above. In other embodiments, a low or no vapor transfer drape might be used. Theinterface sealing member 24 may comprise a range of medically suitable films having a thickness between about 15 microns (μm) to about 50 microns (μm). - In some embodiments, an attachment device or interface layer adhesive 36 may be adapted to be positioned between the
interface sealing member 24 and thetissue site 12. For example, the interface layer adhesive 36 may be positioned on or applied to theinterior facing side 32 of theinterface sealing member 24 for facing thetissue site 12. In some embodiments, theinterface sealing member 24 may be sealed directly against tissue surrounding thetissue site 12, such as theepidermis 14, by theinterface layer adhesive 36. In some embodiments, the interface layer adhesive 36 may seal theinterface sealing member 24 against a gasket or drape adapted to be positioned between the interface layer adhesive 36 and theepidermis 14. - The interface layer adhesive 36 may be a medically-acceptable adhesive and may take numerous forms, such as an adhesive sealing tape, drape tape, paste, hydrocolloid, hydrogel, or other suitable sealing device. The interface layer adhesive 36 may also be flowable. The interface layer adhesive 36 may comprise, without limitation, an acrylic adhesive, rubber adhesive, high-tack silicone adhesive, polyurethane, or other adhesive substance. In some embodiments, the interface layer adhesive 36 may be a pressure-sensitive adhesive comprising an acrylic adhesive with coat weight of 15 grams/m2 (gsm) to 70 grams/m2 (gsm). The pressure-sensitive adhesive may be applied on a side of the
interface sealing member 24 adapted to face theepidermis 14 and thetissue site 12, such as theinterior facing side 32 of theinterface sealing member 24. The pressure-sensitive adhesive may provide a fluid seal between theinterface sealing member 24 and theepidermis 14, and may be utilized in combination with a gasket or drape against theepidermis 14. - In some embodiments, the interface layer adhesive 36 may be a layer or coating applied to or positionable on the
interior facing side 32 of theinterface sealing member 24. In some embodiments, the interface layer adhesive 36 may be continuous or discontinuous. Discontinuities in the interface layer adhesive 36 may be provided by apertures (not shown) in theinterface layer adhesive 36. The apertures or discontinuities in the interface layer adhesive 36 may be, for example, formed after application of the interface layer adhesive 36, or by coating the interface layer adhesive 36 in patterns on theinterior facing side 32 of theinterface sealing member 24. - Referring to
FIGS. 1B and 2B , in some embodiments, the receivingsite 26 may be positioned at or on theexterior facing side 34 of theinterface sealing member 24. A portion of the receivingsite 26 may be adaptable for providing fluid communication between theexterior facing side 34 and theinterior facing side 32 of theinterface sealing member 24. For example, the receivingsite 26 may be in fluid communication with theinterface manifold 22 and the sealedtreatment space 30 through a receivingsite aperture 38 that may be disposed through theinterface sealing member 24. - In some embodiments, the receiving
site 26 may comprise anon-adherent treatment 40. Thenon-adherent treatment 40 may substantially or entirely surround the receivingsite aperture 38. AlthoughFIGS. 1B and 2B depict thenon-adherent treatment 40 as partially covering theexterior facing side 34 of theinterface sealing member 24, thenon-adherent treatment 40 may be applied to the entireexterior facing side 34 in some embodiments. Thenon-adherent treatment 40 may be adapted to releaseably or non-permanently secure components of the system 10 to the receivingsite 26. For example, thenon-adherent treatment 40 may reduce or impair the bond strength of components of the system 10 being applied to the receiving site 10. In some embodiments, thenon-adherent treatment 40 may comprise a coating of a non-adherent material including, without limitation, an olefinic coating, such as a polyethylene or wax; a fluorocarbon coating, such as a polytetrafluoroethylene (PTFE); a highly hydrophilic coating, such as a water soluble or swelling polymer that would retain a high level of moisture capable of reducing bond strength; a coating containing a plasticizer capable of reducing the tackiness of an acrylic or other adhesive; and an ultraviolet (UV) light sensitive coating capable of cross-linking and becoming brittle under the action of UV light. In other embodiments, the substrate material of theinterface sealing member 24 on theexterior facing side 34 may be treated or otherwise modified to have non-adherent properties. - The interface base layer 28 may be adapted to be positioned on the
interior facing side 32 of theinterface sealing member 24 and between theinterface sealing member 24 and thetissue site 12. The interface base layer 28 may enhance the fluid seal between theinterface sealing member 24 and thetissue site 12. The interface base layer 28 may be a soft, pliable material suitable for providing a fluid seal with thetissue site 12 as described herein. For example, the interface base layer 28 may comprise, without limitation, a silicone gel, a soft silicone, hydrocolloid, hydrogel, polyurethane gel, polyolefin gel, hydrogenated styrenic copolymer gel, a foamed gel, a soft closed cell foam such as polyurethanes and polyolefins that may be coated with an adhesive, polyurethane, polyolefin, and hydrogenated styrenic copolymers. In some embodiments, the interface base layer 28 may have a thickness between about 500 microns (μm) and about 1000 microns (μm). In some embodiments, the interface base layer 28 may have a stiffness between about 5 Shore OO to about 80 Shore OO. Further, the interface base layer 28 may be comprised of hydrophobic or hydrophilic materials. - Referring to
FIGS. 1A-1C , in some embodiments, the interface base layer 28 may be aninterface base layer 28 a. Similar to theinterface sealing member 24, theinterface base layer 28 a may be adapted to cover thetissue site 12. A portion of theinterface base layer 28 a may be adapted to overlap tissue surrounding thetissue site 12, such as theepidermis 14, or otherwise surround thetissue site 12. Theinterface base layer 28 a may include a plurality ofinterface layer apertures 42 disposed through opposing sides of theinterface base layer 28 a. Theinterface layer apertures 42 may be adapted to be in fluid communication with the sealedtreatment space 30, theinterface manifold 22, and tissue surrounding thetissue site 12, such as theepidermis 14. The interface layer adhesive 36 may be positioned between theinterface sealing member 24 and theinterface base layer 28 a in fluid communication with tissue surrounding thetissue site 12 through theinterface layer apertures 42. - The
interface layer apertures 42 in theinterface base layer 28 a may have any shape, such as, for example, circles, squares, stars, ovals, polygons, slits, complex curves, rectilinear shapes, triangles, or other shapes. Theinterface layer apertures 42 may be formed by cutting, by application of local RF energy, or other suitable techniques for forming an opening. Theinterface layer apertures 42 may have a diameter between about 6 millimeters to about 50 millimeters. Further, theinterface layer apertures 42 may be uniformly distributed or randomly distributed on theinterface base layer 28 a. - The interface layer adhesive 36 may be in fluid communication with the
interface layer apertures 42 of theinterface base layer 28 a. In this manner, the interface layer adhesive 36 may be in fluid communication with tissue surrounding thetissue site 12 through theinterface layer apertures 42 in theinterface base layer 28 a. As shown inFIG. 1C , the interface layer adhesive 36 may extend or be pressed through theinterface layer apertures 42 to contact, for example, theepidermis 14 for securing the interface dressing 20 a to tissue surrounding thetissue site 12. Theinterface layer apertures 42 may provide sufficient contact of the interface layer adhesive 36 to theepidermis 14 to secure the interface dressing 20 a about thetissue site 12. However, the configuration of theinterface layer apertures 42 and the interface layer adhesive 36, described further below, may permit release and repositioning of the interface dressing 20 a about thetissue site 12. - Factors that may be utilized to control the adhesion strength of the interface dressing 20 a about the
tissue site 12 may include the size and number of theinterface layer apertures 42, the thickness of theinterface base layer 28 a, the thickness and amount of the interface layer adhesive 36, and the tackiness of theinterface layer adhesive 36. For example, an increase in the amount of the interface layer adhesive 36 extending through theinterface layer apertures 42 may correspond to an increase in the adhesion strength of the interface dressing 20 a. Further, a decrease in the thickness of theinterface base layer 28 a may correspond to an increase in the amount of interface layer adhesive 36 extending through theinterface layer apertures 42. Thus, the size and configuration of theinterface layer apertures 42, the thickness of theinterface base layer 28 a, and the amount and tackiness of the interface layer adhesive 36 may be varied to provide a desired adhesion strength for the interface dressing 20 a. In some embodiments, the thickness of theinterface base layer 28 a may be about 200 microns, the interface layer adhesive 36 may have a thickness of about 30 microns and a tackiness of 2000 grams per 25 centimeter wide strip, and the diameter of theinterface layer apertures 42 may be about 6 millimeters. - In some embodiments (not shown), the
interface base layer 28 a may be a hydrophobic-coated material. For example, theinterface base layer 28 a may be formed by coating a spaced material, such as, for example, a woven, nonwoven, molded, or extruded mesh with a hydrophobic material. The hydrophobic material for the coating may be a soft silicone, for example. In this manner, the interface layer adhesive 36 may extend through openings in the spaced material analogous to theinterface layer apertures 42 described above. - Referring to
FIGS. 2A-2C , in some embodiments, the interface base layer 28 may be aninterface base layer 28 b. Theinterface base layer 28 b may be, for example, formed in the shape of a ring or any other suitable shape for surrounding thetissue site 12. While reference is made to a “ring,” discrete members, including linear members, may make up theinterface base layer 28 b in any suitable manner. A ring-like or other suitable shape for theinterface base layer 28 b may save costs by reducing or eliminating material covering thetissue site 12 while still enhancing the fluid seal around thetissue site 12. For example, tissue surrounding thetissue site 12, such as theepidermis 14, may have recesses, cracks, wrinkles, or other discontinuities that may cause leaks. Moreover, folds, buckles, wrinkles, or other discontinuities may form in theinterface sealing member 24 and cause leaks. Theinterface base layer 28 b may reduce any leakage caused by such discontinuities around thetissue site 12. - The
interface base layer 28 b may be formed, as an illustrative example, by applying or bonding a continuous or discontinuous ring of any of the materials recited above for the interface base layer 28 around thetissue site 12 or to a portion of theinterior facing side 32 of theinterface sealing member 24 for positioning between theinterface sealing member 24 and tissue surrounding thetissue site 12. Theinterface base layer 28 b may be coupled directly to theinterface sealing member 24 and tissue surrounding thetissue site 12, or by the interface layer adhesive 36 described above. In some embodiments, theinterface base layer 28 b may comprise, without limitation, hydrocolloids; hydrogels; silicone polymers; crosslinked and uncrosslinked gels; and natural gums such as xanthan, guar, and cellulose. Theinterface base layer 28 b may include other soft polymer gels, such as, for example, those based on polyurethanes, polyolefin gels, and acrylics. - In some embodiments, the
interface base layer 28 b may include an absorbent. The absorbent may permit theinterface base layer 28 b to absorb fluid from thetissue site 12 in addition to enhancing the fluid seal around thetissue site 12. Theinterface base layer 28 b including the absorbent may enhance the ability of the interface dressing 20 b to manage and direct fluid away from thetissue site 12 for keeping thetissue site 12 dry. For example, theinterface base layer 28 b may be a hydrocolloid comprising an absorbent, such as carboxy methyl cellulose (CMC). The absorbent in theinterface base layer 28 b may wick or draw fluid in a lateral direction within the interface dressing 20 b, normal to the thickness of the interface dressing 20 b, and toward the lateral edges of the interface dressing 20 b for absorption in theinterface base layer 28 b. - Referring to
FIGS. 1A-3 , the system 10 may include a second dressing or storage dressing 124, and a reduced-pressure source 128. Thestorage dressing 124 may be positioned in fluid communication with the interface dressing 20 at, for example, the receivingsite 26 of theinterface sealing member 24. Thestorage dressing 124 may be adapted to provide reduced pressure from the reduced-pressure source 128 to theinterface manifold 22, and to store fluid extracted from thetissue site 12 through theinterface manifold 22. In some embodiments, reduced pressure may not be applied, and fluid may be extracted from thetissue site 12 into the storage dressing 124 by wicking action. - The
storage dressing 124 may include astorage base layer 132, astorage layer adhesive 136, astorage sealing member 140, afluid management assembly 144, and aconduit interface 148. Components of the storage dressing 124 may be added or removed to suit a particular application. - Referring to
FIGS. 3-4B , thestorage base layer 132 may have aperiphery 152 surrounding acentral portion 156. A plurality ofstorage layer apertures 160 may be disposed through opposing sides of thestorage base layer 132 and through theperiphery 152 and thecentral portion 156. Thestorage base layer 132 may also havecorners 158 and edges 159. Thecorners 158 and theedges 159 may be part of theperiphery 152. One of theedges 159 may meet another of theedges 159 to define one of thecorners 158. Further, thestorage base layer 132 may have aborder 161 substantially surrounding thecentral portion 156 and positioned between thecentral portion 156 and theperiphery 152. Theborder 161 may be free of thestorage layer apertures 160. - The
storage base layer 132 may cover a portion of theexterior facing side 34 of theinterface sealing member 24. For example, thecentral portion 156 of thebase layer 132 may be positioned adjacent to or proximate to the receivingsite aperture 38, and theperiphery 152 of thebase layer 132 may be positioned adjacent to or proximate to the receivingsite 26 around the receivingsite aperture 38. In this manner, theperiphery 152 of thestorage base layer 132 may surround the receivingsite aperture 38. Further, thestorage layer apertures 160 in thestorage base layer 132 may be in fluid communication with the receivingsite aperture 38 and portions of the receivingsite 26 surrounding the receivingsite aperture 38. - Similar to the
interface layer apertures 42, thestorage layer apertures 160 in thestorage base layer 132 may have any shape, such as, for example, circles, squares, stars, ovals, polygons, slits, complex curves, rectilinear shapes, triangles, or other shapes. Thestorage layer apertures 160 may be formed by cutting, by application of local RF energy, or other suitable techniques for forming an opening. - As shown in
FIGS. 4A-4B , each of thestorage layer apertures 160 of the plurality ofstorage layer apertures 160 may be substantially circular in shape, having a diameter and an area. The area of each of thestorage layer apertures 160 may refer to an open space or open area defining each of thestorage layer apertures 160. The diameter of each of thestorage layer apertures 160 may define the area of each of thestorage layer apertures 160. For example, the area of one of thestorage layer apertures 160 may be defined by multiplying the square of half the diameter of thestorage layer aperture 160 by the value 3.14. Thus, the following equation may define the area of one of the storage layer apertures 160: Area=3.14*(diameter/2){circumflex over ( )}2. - The area of the
storage layer apertures 160 described in the illustrative embodiments herein may be substantially similar to the area in other embodiments (not shown) for thestorage layer apertures 160 that may have non-circular shapes. The diameter of each of thestorage layer apertures 160 may be substantially the same, or each of the diameters may vary depending, for example, on the position of thestorage layer aperture 160 in thestorage base layer 132. For example, the diameter of thestorage layer apertures 160 in theperiphery 152 of thestorage base layer 132 may be larger than the diameter of thestorage layer apertures 160 in thecentral portion 156 of thestorage base layer 132. Further, the diameter of each of thestorage layer apertures 160 may be between about 1 millimeter to about 50 millimeters. In some embodiments, the diameter of each of thestorage layer apertures 160 may be between about 1 millimeter to about 20 millimeters. Thestorage layer apertures 160 may have a uniform pattern or may be randomly distributed on thestorage base layer 132. The size and configuration of thestorage layer apertures 160 may be designed to control the adherence of the storage dressing 124 to the receivingsite 26 of theinterface sealing member 24 as described below. - Continuing with
FIGS. 4A-4B , in some embodiments, thestorage layer apertures 160 positioned in theperiphery 152 may bestorage layer apertures 160 a, thestorage layer apertures 160 positioned at thecorners 158 of theperiphery 152 may bestorage layer apertures 160 b, and thestorage layer apertures 160 positioned in thecentral portion 156 may bestorage layer apertures 160 c. Thestorage layer apertures 160 a may have a diameter between about 9.8 millimeters to about 10.2 millimeters. Thestorage layer apertures 160 b may have a diameter between about 7.75 millimeters to about 8.75 millimeters. Thestorage layer apertures 160 c may have a diameter between about 1.8 millimeters to about 2.2 millimeters. The diameter of each of thestorage layer apertures 160 a may be separated from one another by a distance A between about 2.8 millimeters to about 3.2 millimeters. Further, the diameter of at least one of thestorage layer apertures 160 a may be separated from the diameter of at least one of thestorage layer apertures 160 b by the distance A. The diameter of each of thestorage layer apertures 160 b may also be separated from one another by the distance A. A center of one of thestorage layer apertures 160 c may be separated from a center of another of thestorage layer apertures 160 c in a first direction by a distance B between about 2.8 millimeters to about 3.2 millimeters. In a second direction transverse to the first direction, the center of one of thestorage layer apertures 160 c may be separated from the center of another of thestorage layer apertures 160 c by a distance C between about 2.8 millimeters to about 3.2 millimeters. As shown inFIGS. 4A-4B , the distance B and the distance C may be increased for thestorage layer apertures 160 c in thecentral portion 156 being positioned proximate to or at theborder 161 compared to thestorage layer apertures 160 c positioned away from theborder 161. - The
central portion 156 of thestorage base layer 132 may be substantially square with each side of thecentral portion 156 having a length D between about 100 millimeters to about 108 millimeters. In some embodiments, the length D may be between about 106 millimeters to about 108 millimeters. Theborder 161 of thestorage base layer 132 may have a width E between about 4 millimeters to about 11 millimeters and may substantially surround thecentral portion 156 and thestorage layer apertures 160 c in thecentral portion 156. In some embodiments, the width E may be between about 9 millimeters to about 10 millimeters. Theperiphery 152 of thestorage base layer 132 may have a width F between about 25 millimeters to about 35 millimeters and may substantially surround theborder 161 and thecentral portion 156. In some embodiments, the width F may be between about 26 millimeters to about 28 millimeters. Further, theperiphery 152 may have a substantially square exterior with each side of the exterior having a length G between about 154 millimeters to about 200 millimeters. In some embodiments, the length G may be between about 176 millimeters to about 184 millimeters. AlthoughFIGS. 4A-4B depict thecentral portion 156, theborder 161, and theperiphery 152 of thestorage base layer 132 as having a substantially square shape, these and other components of thestorage base layer 132 may have any shape to suit a particular application. Further, the dimensions of thestorage base layer 132 as described herein may be increased or decreased, for example, substantially in proportion to one another to suit a particular application. - The
storage base layer 132 may be a soft, pliable material suitable for providing a fluid seal as described herein. For example, thestorage base layer 132 may comprise a silicone gel, a soft silicone, hydrocolloid, hydrogel, polyurethane gel, polyolefin gel, hydrogenated styrenic copolymer gels, a foamed gel, a soft closed cell foam such as polyurethanes and polyolefins that may be coated with an adhesive, polyurethane, polyolefin, and hydrogenated styrenic copolymers. In some embodiments, thestorage base layer 132 may have a thickness between about 500 microns (μm) to about 1000 microns (μm). In some embodiments, thestorage base layer 132 may have a stiffness between about 5 Shore OO to about 80 Shore OO. Further, thestorage base layer 132 may be comprised of hydrophobic or hydrophilic materials. - In some embodiments (not shown), the
storage base layer 132 may be a hydrophobic-coated material. For example, thestorage base layer 132 may be formed by coating a spaced material, such as, for example, a woven, nonwoven, molded, or extruded mesh with a hydrophobic material. The hydrophobic material for the coating may be a soft silicone, for example. In this manner, the storage layer adhesive 136 may extend through openings in the spaced material analogous to thestorage layer apertures 160 as described below. - The storage layer adhesive 136 may be in fluid communication with the
storage layer apertures 160 in at least theperiphery 152 of thestorage base layer 132. In this manner, the storage layer adhesive 136 may be in fluid communication with a portion of the receivingsite 26 surrounding the receivingsite aperture 38 through thestorage layer apertures 160. Analogous to the interface layer adhesive 36 inFIG. 1C , the storage layer adhesive 136 may extend or be pressed through the plurality ofstorage layer apertures 160 to contact the receivingsite 26 for securing the storage dressing 124 to theinterface sealing member 24 of the interface dressing 20. Thestorage layer apertures 160 may provide sufficient contact of the storage layer adhesive 136 to the receivingsite 26 to secure the storage dressing 124 about the receivingsite aperture 38. However, the configuration of thestorage layer apertures 160 and thestorage layer adhesive 136, described below, may permit release and repositioning of the storage dressing 124 on the receivingsite 26. - Continuing with
FIGS. 4A-4B , at least one of thestorage layer apertures 160 a in theperiphery 152 of thestorage base layer 132 may be positioned at theedges 159 of theperiphery 152 and may have an interior cut open or exposed at theedges 159 that is in fluid communication in a lateral direction with theedges 159. The lateral direction may refer to a direction toward theedges 159 and in the same plane as thestorage base layer 132. A plurality of thestorage layer apertures 160 a in theperiphery 152 may be positioned proximate to or at theedges 159 and in fluid communication in a lateral direction with theedges 159. Thestorage layer apertures 160 a positioned proximate to or at theedges 159 may be spaced substantially equidistant around theperiphery 152 as shown inFIGS. 4A-4B . However, in some embodiments, the spacing of thestorage layer apertures 160 a proximate to or at theedges 159 may be irregular. The storage layer adhesive 136 may be in fluid communication with theedges 159 through thestorage layer apertures 160 a being exposed at theedges 159. In this manner, thestorage layer apertures 160 a at theedges 159 may permit the storage layer adhesive 136 to flow around theedges 159 for enhancing the adhesion of theedges 159 around the receivingsite 26, for example. - The
storage layer apertures 160 b at thecorners 158 of theperiphery 152 may be smaller than thestorage layer apertures 160 a in other portions of theperiphery 152 as described above. For a given geometry of thecorners 158, the smaller size of thestorage layer apertures 160 b compared to thestorage layer apertures 160 a may maximize the surface area of the storage layer adhesive 136 exposed and in fluid communication through thestorage layer apertures 160 b at thecorners 158. For example, as shown inFIGS. 4A-4B , theedges 159 may intersect at substantially a right angle, or about 90 degrees, to define thecorners 158. Also as shown, thecorners 158 may have a radius of about 10 millimeters. Three of thestorage layer apertures 160 b having a diameter between about 7.75 millimeters to about 8.75 millimeters may be positioned in a triangular configuration at thecorners 158 to maximize the exposed surface area for thestorage layer adhesive 136. The size and number of thestorage layer apertures 160 b in thecorners 158 may be adjusted as necessary, depending on the chosen geometry of thecorners 158, to maximize the exposed surface area of the storage layer adhesive 136 as described above. Further, thestorage layer apertures 160 b at thecorners 158 may be fully housed within thestorage base layer 132, substantially precluding fluid communication in a lateral direction exterior to thecorners 158. Thestorage layer apertures 160 b at thecorners 158 being fully housed within thestorage base layer 132 may substantially preclude fluid communication of the storage layer adhesive 136 exterior to thecorners 159, and may provide improved handling of the storage dressing 124 during deployment. Further, the exterior of thecorners 158 being substantially free of the storage layer adhesive 136 may increase the flexibility of thecorners 158 to enhance comfort. - Similar to the
storage layer apertures 160 b in thecorners 158, any of thestorage layer apertures 160 may be adjusted in size and number to maximize the surface area of the storage layer adhesive 136 in fluid communication through thestorage layer apertures 160 for a particular application or geometry of thestorage base layer 132. For example, in some embodiments (not shown) thestorage layer apertures 160 b, or apertures of another size, may be positioned in theperiphery 152 and at theborder 161. Similarly, thestorage layer apertures 160 b, or apertures of another size, may be positioned as described above in other locations of thestorage base layer 132 that may have a complex geometry or shape. - Similar to the interface layer adhesive 36, the storage layer adhesive 136 may be a medically-acceptable adhesive. The storage layer adhesive 136 may also be flowable. For example, the storage layer adhesive 136 may comprise an acrylic adhesive, rubber adhesive, high-tack silicone adhesive, polyurethane, or other adhesive substance. In some embodiments, the storage layer adhesive 136 may be a pressure-sensitive adhesive comprising an acrylic adhesive with coat weight of 15 grams/m2 (gsm) to 70 grams/m2 (gsm). The storage layer adhesive 136 may be a layer having substantially the same shape as the
periphery 152 of thestorage base layer 132 as shown inFIG. 4A . In some embodiments, the storage layer adhesive 136 may be a continuous or discontinuous layer. Discontinuities in the storage layer adhesive 136 may be provided by apertures (not shown) in thestorage layer adhesive 136. The apertures in the storage layer adhesive 136 may be formed after application of the storage layer adhesive 136 or by coating the storage layer adhesive 136 in patterns, for example, on a side of thestorage sealing member 140 adapted to face the receivingsite 26. Further, the apertures in the storage layer adhesive 136 may be sized to control the amount of the storage layer adhesive 136 extending through thestorage layer apertures 160 in thestorage base layer 132 to reach the receivingsite 26. The apertures in the storage layer adhesive 136 may also be sized to enhance the Moisture Vapor Transfer Rate (MVTR) of thestorage dressing 124, described further below. - Factors that may be utilized to control the adhesion strength of the storage dressing 124 may include the diameter and number of the
storage apertures 160 in thestorage base layer 132, the thickness of thestorage base layer 132, the thickness and amount of thestorage layer adhesive 136, and the tackiness of thestorage layer adhesive 136. An increase in the amount of the storage layer adhesive 136 extending through thestorage layer apertures 160 may correspond to an increase in the adhesion strength of thestorage dressing 124. A decrease in the thickness of thestorage base layer 132 may correspond to an increase in the amount of the storage layer adhesive 136 extending through thestorage layer apertures 160. Thus, the diameter and configuration of thestorage layer apertures 160, the thickness of thestorage base layer 132, and the amount and tackiness of the storage layer adhesive 136 may be varied to provide a desired adhesion strength for thestorage dressing 124. For example, the thickness of thestorage base layer 132 may be about 200 microns, the storage layer adhesive 136 may have a thickness of about 30 microns and a tackiness of 2000 grams per 25 centimeter wide strip, and the diameter of thestorage layer apertures 160 a may be about 10 millimeters. - In some embodiments, the tackiness of the storage layer adhesive 136 may vary in different locations of the
storage base layer 132. For example, in locations of thestorage base layer 132 where thestorage layer apertures 160 are comparatively large, such as thestorage layer apertures 160 a, the storage layer adhesive 136 may have a lower tackiness than other locations of thestorage base layer 132 where thestorage layer apertures 160 are smaller, such as thestorage layer apertures storage base layer 132 having largerstorage layer apertures 160 and lower tackiness storage layer adhesive 136 may have an adhesion strength comparable to locations having smallerstorage layer apertures 160 and higher tackinessstorage layer adhesive 136. - Referring to
FIG. 4B , arelease liner 162 may be attached to or positioned adjacent to thestorage base layer 132 to protect thestorage layer adhesive 136 prior to application of the storage dressing 124 to the receivingsite 26. Prior to application of thestorage dressing 124, thestorage base layer 132 may be positioned between thestorage sealing member 140 and therelease liner 162. Removal of therelease liner 162 may expose thestorage base layer 132 and thestorage layer adhesive 136 for application of the storage dressing 124 to the receivingsite 26. Therelease liner 162 may also provide stiffness to assist with deployment of thestorage dressing 124. - The
release liner 162 may be, for example, a casting paper, a film, or polyethylene. Further, therelease liner 162 may be a polyester material such as polyethylene terephthalate (PET), or similar polar semi-crystalline polymer. The use of a polar semi-crystalline polymer for therelease liner 162 may substantially preclude wrinkling or other deformation of thestorage dressing 124. For example, the polar semi-crystalline polymer may be highly orientated and resistant to softening, swelling, or other deformation that may occur when brought into contact with components of thestorage dressing 124, or when subjected to temperature or environmental variations, or sterilization. Further, a release agent may be disposed on a side of therelease liner 162 that is configured to contact thestorage base layer 132. For example, the release agent may be a silicone coating and may have a release factor suitable to facilitate removal of therelease liner 162 by hand and without damaging or deforming thestorage dressing 124. In some embodiments, the release agent may be flourosilicone. In other embodiments, therelease liner 162 may be uncoated or otherwise used without a release agent. - Referring to
FIGS. 3-4B , thestorage sealing member 140 may have aperiphery 164 and acentral portion 168. Thestorage sealing member 140 may additionally include anaperture 170, as described below. Theperiphery 164 of thestorage sealing member 140 may be positioned proximate to theperiphery 152 of thestorage base layer 132 such that thecentral portion 168 of thestorage sealing member 140 and thecentral portion 156 of thestorage base layer 132 define anenclosure 172. The storage layer adhesive 136 may be positioned at least between theperiphery 164 of thestorage sealing member 140 and theperiphery 152 of thestorage base layer 132. Thestorage sealing member 140 may cover the receivingsite 26 and the receivingsite aperture 38 to provide a fluid seal and a sealedstorage space 174 between the receivingsite 26 and thestorage sealing member 140. Thestorage base layer 132 may be positioned between thestorage sealing member 140 and the receivingsite 26 of theinterface sealing member 24. The sealedstorage space 174 may be in fluid communication with the sealedtreatment space 30 through the receivingsite aperture 38, for example. Further, theenclosure 172 may provide a portion of the sealedstorage space 174 when thestorage sealing member 140 is positioned at the receivingsite 26 as described. - In some embodiments, a portion of the
periphery 164 of thestorage sealing member 140 may extend beyond theperiphery 152 of thestorage base layer 132 and into direct contact with the receivingsite 26. In other embodiments, theperiphery 164 of thestorage sealing member 140, for example, may be positioned in contact with the receivingsite 26 to provide the sealedstorage space 174 without thestorage base layer 132. Thus, the storage layer adhesive 136 may be positioned between at least theperiphery 164 of thestorage sealing member 140 and the receivingsite 26. The storage layer adhesive 136 may be disposed on a surface of thestorage sealing member 140 adapted to face the receivingsite 26 and thestorage base layer 132. - Similar to the
interface sealing member 24, thestorage sealing member 140 may be formed from any material that allows for a fluid seal. A fluid seal may be a seal adequate to maintain reduced pressure at a desired site, if applicable. Thestorage sealing member 140 may comprise, for example, one or more of the following materials without limitation: hydrophilic polyurethane; cellulosics; hydrophilic polyamides; polyvinyl alcohol; polyvinyl pyrrolidone; hydrophilic acrylics; hydrophilic silicone elastomers; an INSPIRE 2301 material from Expopack Advanced Coatings of Wrexham, United Kingdom having, for example, an MVTR (inverted cup technique) of 14400 g/m2/24 hours and a thickness of about 30 microns; a thin, uncoated polymer drape; natural rubbers; polyisoprene; styrene butadiene rubber; chloroprene rubber; polybutadiene; nitrile rubber; butyl rubber; ethylene propylene rubber; ethylene propylene diene monomer; chlorosulfonated polyethylene; polysulfide rubber; polyurethane (PU); EVA film; co-polyester; silicones; a silicone drape; a 3M Tegaderm® drape; a polyurethane (PU) drape such as one available from Avery Dennison Corporation of Pasadena, Calif.; polyether block polyamide copolymer (PEBAX), for example, from Arkema, France; Expopack 2327; or other appropriate material. - The
storage sealing member 140 may be vapor permeable and liquid impermeable, thereby allowing vapor and inhibiting liquids from exiting the sealedstorage space 174 provided by thestorage dressing 124. In some embodiments, thestorage sealing member 140 may be a flexible, breathable film, membrane, or sheet having a high MVTR of, for example, at least about 300 g/m2 per 24 hours. In other embodiments, a low or no vapor transfer drape might be used. Thestorage sealing member 140 may comprise a range of medically suitable films having a thickness between about 15 microns (μm) to about 50 microns (μm). - The
fluid management assembly 144 may be disposed in theenclosure 172 and may include afirst wicking layer 176, asecond wicking layer 180, and anabsorbent layer 184. Theabsorbent layer 184 may be positioned in fluid communication between thefirst wicking layer 176 and thesecond wicking layer 180. Thefirst wicking layer 176 may have a grain structure (not shown) adapted to wick fluid along a surface of thefirst wicking layer 176. Similarly, thesecond wicking layer 180 may have a grain structure (not shown) adapted to wick fluid along a surface of thesecond wicking layer 180. For example, thefirst wicking layer 176 and thesecond wicking layer 180 may wick or otherwise transport fluid in a lateral direction along the surfaces of thefirst wicking layer 176 and thesecond wicking layer 180, respectively. The surfaces of thefirst wicking layer 176 and thesecond wicking layer 180 may be normal relative to the thickness of each of thefirst wicking layer 176 and thesecond wicking layer 180. The wicking of fluid along thefirst wicking layer 176 and thesecond wicking layer 180 may enhance the distribution of the fluid over a surface area of theabsorbent layer 184 that may increase absorbent efficiency and resist fluid blockages. Fluid blockages may be caused by, for example, fluid pooling in a particular location in theabsorbent layer 184 rather than being distributed more uniformly across theabsorbent layer 184. The laminate combination of thefirst wicking layer 176, thesecond wicking layer 180, and theabsorbent layer 184 may be adapted as described above to maintain an open structure, resistant to blockage, capable of maintaining fluid communication with, for example, the interface dressing 20. - Referring to the embodiments of the
fluid management assembly 144 depicted inFIGS. 1A, 2A, 3, 5, and 6 , aperipheral portion 186 of thefirst wicking layer 176 may be coupled to aperipheral portion 187 of thesecond wicking layer 180 to define awicking layer enclosure 188 between thefirst wicking layer 176 and thesecond wicking layer 180. In some exemplary embodiments, thewicking layer enclosure 188 may surround or otherwise encapsulate theabsorbent layer 184 between thefirst wicking layer 176 and thesecond wicking layer 180. - Referring to
FIGS. 5 and 6 , thefluid management assembly 144 may include, without limitation, any number of wicking layers and absorbent layers as desired for treating a particular tissue site. For example, theabsorbent layer 184 may be a plurality ofabsorbent layers 184 positioned in fluid communication between thefirst wicking layer 176 and thesecond wicking layer 180 as described above. Further, as depicted inFIG. 6 , at least oneintermediate wicking layer 189 may be disposed in fluid communication between the plurality ofabsorbent layers 184. Similar to theabsorbent layer 184 described above, the plurality ofabsorbent layers 184 and the at least oneintermediate wicking layer 189 may be positioned within thewicking layer enclosure 188. - In some embodiments, components of the storage dressing 124 may be removed to suit different applications or to reduce material cost. For example, the
absorbent layer 184 may be disposed between thestorage sealing member 140 and the receivingsite 26 with thestorage base layer 132, thefirst wicking layer 176, and thesecond wicking layer 180 omitted. Thus, thestorage sealing member 140 may cover theabsorbent layer 184 at the receivingsite 26, and theabsorbent layer 184 may be sized for positioning in the sealedstorage space 174 adjacent to or in direct contact with the receivingsite 26. Further, the receivingsite aperture 38 may provide fluid communication between theabsorbent layer 184 and theinterface manifold 22. Thenon-adherent treatment 40 may be adapted to releaseably or non-permanently secure thestorage sealing member 140 to the receivingsite 26 as described herein. - In the embodiments of
FIGS. 5 and 6 ,sides 184 a of theabsorbent layers 184 may remain in fluid communication with one another for enhancing efficiency. Similarly, in the embodiment ofFIG. 6 ,sides 189 a of the at least oneintermediate wicking layer 189 may remain in fluid communication with one another and with thesides 184 a of the absorbent layers 184. Further, including additionalabsorbent layers 184 may increase the absorbent mass of thefluid management assembly 144 and generally provide greater fluid capacity. However, for a given absorbent mass, multiple light coat-weightabsorbent layers 184 may be utilized rather than a single heavy coat-weightabsorbent layer 184 to provide a greater absorbent surface area for further enhancing the absorbent efficiency. - In some embodiments, the
absorbent layer 184 may be a hydrophilic material adapted to absorb fluid from, for example, thetissue site 12. Materials suitable for theabsorbent layer 184 may include Luquafleece® material, Texsus FP2326, BASF 402C, Technical Absorbents 2317 available from Technical Absorbents (www.techabsorbents.com), sodium polyacrylate super absorbers, cellulosics (carboxy methyl cellulose and salts such as sodium CMC), or alginates. Materials suitable for thefirst wicking layer 176 and thesecond wicking layer 180 may include any material having a grain structure capable of wicking fluid as described herein, such as, for example, Libeltex TDL2 80 gsm. - The
fluid management assembly 144 may be a pre-laminated structure manufactured at a single location or individual layers of material stacked upon one another as described above. Individual layers of thefluid management assembly 144 may be bonded or otherwise secured to one another without adversely affecting fluid management by, for example, utilizing a solvent or non-solvent adhesive, or by thermal welding. Further, thefluid management assembly 144 may be coupled to theborder 161 of thebase layer 132 in any suitable manner, such as, for example, by a weld or an adhesive. Theborder 161 being free of theapertures 160 as described above may provide a flexible barrier between thefluid management assembly 144 and the tissue site 104 for enhancing comfort. - In some embodiments, the
enclosure 172 defined by thestorage base layer 132 and thestorage sealing member 140 may include ananti-microbial layer 190. The addition of theanti-microbial layer 190 may reduce the probability of excessive bacterial growth within the storage dressing 124 to permit the storage dressing 124 to remain in place for an extended period. Theanti-microbial layer 190 may be, for example, an additional layer included as a part of thefluid management assembly 144 as depicted inFIG. 3 , or a coating of an anti-microbial agent disposed in any suitable location within thestorage dressing 124. Theanti-microbial layer 190 may be comprised of elemental silver or similar compound, for example. In some embodiments, the anti-microbial agent may be formulated in any suitable manner into other components of thestorage dressing 124. - Referring to
FIGS. 1A, 2A, 3, and 7 , theconduit interface 148 may be positioned proximate to thestorage sealing member 140 and in fluid communication with the storage dressing 124 through theaperture 170 in thestorage sealing member 140 to provide reduced pressure from the reduced-pressure source 128 to thestorage dressing 124. Specifically, theconduit interface 148 may be positioned in fluid communication with theenclosure 172, including theabsorbent layer 184, of thestorage dressing 124. Theconduit interface 148 may also be positioned in fluid communication with theinterface manifold 22. - The
conduit interface 148 may comprise a medical-grade, soft polymer or other pliable material. As non-limiting examples, theconduit interface 148 may be formed from polyurethane, polyethylene, polyvinyl chloride (PVC), fluorosilicone, or ethylene-propylene, etc. In some illustrative, non-limiting embodiments, theconduit interface 148 may be molded from DEHP-free PVC. Theconduit interface 148 may be formed in any suitable manner such as by molding, casting, machining, or extruding. Further, theconduit interface 148 may be formed as an integral unit or as individual components and may be coupled to the storage dressing 124 by, for example, adhesive or welding. - In some embodiments, the
conduit interface 148 may be formed of an absorbent material having absorbent and evaporative properties. The absorbent material may be vapor permeable and liquid impermeable, thereby being configured to permit vapor to be absorbed into and evaporated from the material through permeation while inhibiting permeation of liquids. The absorbent material may be, for example, a hydrophilic polymer such as a hydrophilic polyurethane. Although the term hydrophilic polymer may be used in the illustrative embodiments that follow, any absorbent material having the properties described herein may be suitable. Further, the absorbent material or hydrophilic polymer may be suitable for use in various components of the system 10 as described herein. - The use of such a hydrophilic polymer for the
conduit interface 148 may permit liquids in theconduit interface 148 to evaporate, or otherwise dissipate, during operation. For example, the hydrophilic polymer may allow the liquid to permeate or pass through theconduit interface 148 as vapor, in a gaseous phase, and evaporate into the atmosphere external to theconduit interface 148. Such liquids may be, for example, condensate or other liquids. Condensate may form, for example, as a result of a decrease in temperature within theconduit interface 148, or other components of the system 10, relative to the temperature at thetissue site 12. Removal or dissipation of liquids from theconduit interface 148 may increase visual appeal and prevent odor. Further, such removal of liquids may also increase efficiency and reliability by reducing blockages and other interference with the components of the system 10. - Similar to the
conduit interface 148, other components of the system 10 may be formed of an absorbent material or a hydrophilic polymer. The absorptive and evaporative properties of the hydrophilic polymer may also facilitate removal and dissipation of liquids residing in other components of the system 10 by evaporation. Such evaporation may leave behind a substantially solid or gel-like waste. The substantially solid or gel-like waste may be cheaper to dispose than liquids, providing a cost savings for operation of the system 10. The hydrophilic polymer may be used for other components in the system 10 where the management of liquids is beneficial. - In some embodiments, the absorbent material or hydrophilic polymer may have an absorbent capacity in a saturated state that is substantially equivalent to the mass of the hydrophilic polymer in an unsaturated state. The hydrophilic polymer may be fully saturated with vapor in the saturated state and substantially free of vapor in the unsaturated state. In both the saturated state and the unsaturated state, the hydrophilic polymer may retain substantially the same physical, mechanical, and structural properties. For example, the hydrophilic polymer may have a hardness in the unsaturated state that is substantially the same as a hardness of the hydrophilic polymer in the saturated state. The hydrophilic polymer and the components of the system 10 incorporating the hydrophilic polymer may also have a size that is substantially the same in both the unsaturated state and the saturated state. Further, the hydrophilic polymer may remain dry, cool to the touch, and pneumatically sealed in the saturated state and the unsaturated state. The hydrophilic polymer may also remain substantially the same color in the saturated state and the unsaturated state. In this manner, this hydrophilic polymer may retain sufficient strength and other physical properties to remain suitable for use in the system 10. An example of such a hydrophilic polymer is offered under the trade name Techophilic HP-93A-100, available from The Lubrizol Corporation of Wickliffe, Ohio, United States. Techophilic HP-93A-100 is an absorbent hydrophilic thermoplastic polyurethane capable of absorbing 100% of the unsaturated mass of the polyurethane in water and having a durometer or Shore Hardness of about 83 Shore A.
- The
conduit interface 148 may carry anodor filter 194 adapted to substantially preclude the passage of odors from thetissue site 12 out of the sealedstorage space 174. Further, theconduit interface 148 may carry a primaryhydrophobic filter 195 adapted to substantially preclude the passage of liquids out of the sealedstorage space 174. Theodor filter 194 and the primaryhydrophobic filter 195 may be disposed in theconduit interface 148, or other suitable location, such that fluid communication between the reduced-pressure source 128 and thestorage dressing 124 is provided through theodor filter 194 and the primaryhydrophobic filter 195. In some embodiments, theodor filter 194 and the primaryhydrophobic filter 195 may be secured within theconduit interface 148 in any suitable manner, such as by adhesive or welding. In other embodiments, theodor filter 194 and the primaryhydrophobic filter 195 may be positioned in any exit location in the storage dressing 124 that is in fluid communication with the atmosphere or the reduced-pressure source 128. Theodor filter 194 may also be positioned in any suitable location in the system 10 that is in fluid communication with thetissue site 12. - The
odor filter 194 may be comprised of a carbon material in the form of a layer or particulate. For example, theodor filter 194 may comprise a woven carbon cloth filter such as those manufactured by Chemviron Carbon, Ltd. of Lancashire, United Kingdom (www.chemvironcarbon.com). The primaryhydrophobic filter 195 may be comprised of a material that is liquid impermeable and vapor permeable. For example, the primaryhydrophobic filter 195 may comprise a material manufactured under the designation MMT-314 or MMT-332 by W.L. Gore & Associates, Inc. of Newark, Del., United States, or similar materials. The primaryhydrophobic filter 195 may be provided in the form of a membrane or layer. Further, in some embodiments, thefilter 195 may be an oleophobic filter. - Referring to
FIGS. 1A and 2A , the reduced-pressure source 128 may provide reduced pressure as part of the system 10. The reduced-pressure source 128 may be positioned in fluid communication with theinterface manifold 22. In some embodiments, the reduce-pressure source 128 may be in fluid communication with theinterface manifold 22 through at least theabsorbent layer 184. The reduced-pressure source 128 may be any suitable device for providing reduced pressure, such as, for example, a vacuum pump, wall suction, hand pump, or other source. - As used herein, “reduced pressure” may refer to a pressure less than the ambient pressure at a tissue site being subjected to treatment. In some embodiments, the reduced pressure may be less than the atmospheric pressure. The reduced pressure may also be less than a hydrostatic pressure at a tissue site. Unless otherwise indicated, values of pressure stated herein are gauge pressures. While the amount and nature of reduced pressure applied to a tissue site may vary according to the application, in some embodiments, the reduced pressure may be between about −5 mm Hg to about −500 mm Hg. In other embodiments, the reduced pressure may be between about −100 mm Hg to about −200 mm Hg.
- The reduced pressure delivered may be constant or varied (patterned or random), and may be delivered continuously or intermittently. Although the terms “vacuum” and “negative pressure” may be used to describe the pressure applied to a tissue site, the actual pressure applied to the tissue site may be more than the pressure normally associated with a complete vacuum. Consistent with the use herein, an increase in reduced pressure or vacuum pressure may refer to a relative reduction in absolute pressure. An increase in reduced pressure may correspond to a reduction in pressure (more negative relative to ambient pressure) and a decrease in reduced pressure may correspond to an increase in pressure (less negative relative to ambient pressure).
- As shown in
FIGS. 1A, 2A, 3, and 7 , aconduit 196 having aninternal lumen 197 may be coupled in fluid communication between the reduced-pressure source 128 and thestorage dressing 124. Theinternal lumen 197 may have an internal diameter between about 0.5 millimeters to about 3.0 millimeters. In some embodiments, the internal diameter of theinternal lumen 197 may be between about 1 millimeter to about 2 millimeters. Theconduit interface 148 may be coupled in fluid communication with thestorage dressing 124 and adapted to connect between theconduit 196 and the storage dressing 124 for providing fluid communication with the reduced-pressure source 128. Theconduit interface 148 may be fluidly coupled to theconduit 196 in any suitable manner, such as, for example, by an adhesive, solvent or non-solvent bonding, welding, or interference fit. Theaperture 170 in thestorage sealing member 140 may provide fluid communication between thestorage dressing 124 and theconduit interface 148. Theconduit interface 148 may be in fluid communication with theenclosure 172 and the sealedstorage space 174 through theaperture 170 in thestorage sealing member 140. In some embodiments, theconduit 196 may be inserted into the storage dressing 124 through theaperture 170 in thestorage sealing member 140 to provide fluid communication with the reduced-pressure source 128 without use of theconduit interface 148. The reduced-pressure source 128 may also be directly coupled in fluid communication with the storage dressing 124 or thestorage sealing member 140 without use of theconduit 196. Theconduit 196 may be, for example, a flexible polymer tube. A distal end of theconduit 196 may include acoupling 198 for attachment to the reduced-pressure source 128. - The
conduit 196 may have a secondaryhydrophobic filter 199 disposed in theinternal lumen 197 such that fluid communication between the reduced-pressure source 128 and thestorage dressing 124 is provided through the secondaryhydrophobic filter 199. The secondaryhydrophobic filter 199 may be, for example, a porous, sintered polymer cylinder sized to fit the dimensions of theinternal lumen 197 to substantially preclude liquid from bypassing the cylinder. The secondaryhydrophobic filter 199 may also be treated with an absorbent material adapted to swell when brought into contact with liquid to block the flow of the liquid. The secondaryhydrophobic filter 199 may be positioned at any location within theinternal lumen 197. However, positioning the secondaryhydrophobic filter 199 within theinternal lumen 197 closer toward the reduced-pressure source 128, rather than thestorage dressing 124, may allow a user to detect the presence of liquid in theinternal lumen 197. - In some embodiments, the
conduit 196 and thecoupling 198 may be formed of an absorbent material or a hydrophilic polymer as described above for theconduit interface 148. In this manner, theconduit 196 and thecoupling 198 may permit liquids in theconduit 196 and thecoupling 198 to evaporate, or otherwise dissipate, as described above for theconduit interface 148. Theconduit 196 and thecoupling 198 may be, for example, molded from the hydrophilic polymer separately, as individual components, or together as an integral component. Further, a wall of theconduit 196 defining theinternal lumen 197 may be extruded from the hydrophilic polymer. Theconduit 196 may be less than about 1 meter in length, but may have any length to suit a particular application. In some embodiments, a length of about 1 foot or 304.8 millimeters may provide enough absorbent and evaporative surface area to suit many applications, and may provide a cost savings compared to longer lengths. If an application requires additional length for theconduit 196, the absorbent hydrophilic polymer may be coupled in fluid communication with a length of conduit formed of a non-absorbent hydrophobic polymer to provide additional cost savings. - According to an illustrative embodiment of operation of the system 10, the
interface manifold 22 may be disposed against or proximate to thetissue site 12. Theinterior facing side 32 of theinterface sealing member 24 may be positioned to cover theinterface manifold 22 at thetissue site 12 and tissue surrounding thetissue site 12. The interface base layer 28 and/or the interface layer adhesive 36 may be configured and positioned as described above for providing the sealedtreatment space 30 between theinterface sealing member 24 and thetissue site 12. The receivingsite aperture 38 may be cut through theinterface sealing member 24, the interface base layer 28, and the interface layer adhesive 36 as applicable and in any suitable manner for providing fluid communication between the receivingsite 26 and theinterface manifold 22. - The
storage dressing 124 may be applied over the receivingsite 26 of the interface dressing 20 and about the receivingsite aperture 38 to form the sealedstorage space 174. In some embodiments, thestorage base layer 132 may be applied covering the receivingsite aperture 38 and a portion of the receivingsite 26 surrounding the receivingsite aperture 38. Once thestorage dressing 124 is in the desired position, a force may be applied, for example, by hand, on an exterior of thestorage sealing member 140. The force applied to thestorage sealing member 140 may cause at least some portion of the storage layer adhesive 136 to penetrate or extend through thestorage layer apertures 160 and into contact with the receivingsite 26 to releaseably adhere the storage dressing 124 about the receivingsite 26. In this manner, the configuration of the storage dressing 124 described above may provide a reliable seal against the receivingsite 26 while permitting removal and repositioning of the storage dressing 124 on the interface dressing 20 without damaging theinterface sealing member 24. Further, thenon-adherent treatment 40 at the receivingsite 26 may further enhance the ability of a user to reposition or remove the storage dressing 124 for replacement. - As the interface dressing 20 and the storage dressing 124 come into contact with fluid from the
tissue site 12, the fluid may move through thestorage layer apertures 160 toward thefluid management assembly 144 in thestorage dressing 124. Thefluid management assembly 144 may wick or otherwise move the fluid through theinterface manifold 22 and away from thetissue site 12. As described above, theinterface manifold 22 may be adapted to communicate fluid from thetissue site 12 rather than store the fluid. Thus, thefluid management assembly 144 may be more absorbent than theinterface manifold 22. Thefluid management assembly 144 being more absorbent than theinterface manifold 22 may provide an absorbent gradient that may attract fluid from thetissue site 12 or theinterface manifold 22 to thefluid management assembly 144. Thus, in some embodiments, thefluid management assembly 144 may be adapted to wick, pull, draw, or otherwise attract fluid from thetissue site 12 through theinterface manifold 22. In thefluid management assembly 144, the fluid may initially come into contact with thefirst wicking layer 176. Thefirst wicking layer 176 may distribute the fluid laterally along the surface of thefirst wicking layer 176 as described above for absorption and storage within theabsorbent layer 184. Similarly, fluid coming into contact with thesecond wicking layer 180 may be distributed laterally along the surface of thesecond wicking layer 180 for absorption within theabsorbent layer 184. - In some embodiments, a method of treating the
tissue site 12 may include positioning the interface dressing 20 on thetissue site 12 and in fluid communication with thetissue site 12. Further, the method may include releaseably securing the storage dressing 124 to the interface dressing 20 in fluid communication with the interface dressing 20, and applying reduced pressure to thestorage dressing 124. Further, the method may include extracting fluid from thetissue site 12 through the interface dressing 20, and storing fluid extracted through the interface dressing 20 within thestorage dressing 124. Thestorage dressing 124 may be in fluid communication with thetissue site 12 through the interface dressing 20. In some embodiments, thenon-adherent treatment 40 may be positioned between the interface dressing 20 and thestorage dressing 124. - In some embodiments, the storage dressing 124 may be a first storage dressing and the method may further include removing the first storage dressing from the interface dressing 20; and replacing the first storage dressing with a second storage dressing. In some embodiments, the second storage dressing may be releaseably secured to the interface dressing 20 in fluid communication with the interface dressing 20 after removing the first storage dressing. In some embodiments, removing the first storage dressing from the interface dressing 20 may occur after the first storage dressing is substantially full of fluid.
- In some embodiments, the interface dressing 20 may include an
interface manifold 22 and aninterface sealing member 24. Positioning the interface dressing 20 on thetissue site 12 may include: positioning theinterface manifold 22 on thetissue site 12 in fluid communication with thetissue site 12; and covering theinterface manifold 22 and tissue surrounding thetissue site 12 with theinterface sealing member 24 to provide a sealedtreatment space 30 between theinterface sealing member 24 and thetissue site 12. - In some embodiments, the method may include forming an
aperture 38 through theinterface sealing member 24. Theaperture 38 may be adapted to provide fluid communication with theinterface manifold 22 through theinterface sealing member 24. In some embodiments, forming theaperture 38 through theinterface sealing member 24 may occur before releaseably securing the storage dressing 124 to the interface dressing 20. - In some embodiments, the storage dressing 124 may include the
absorbent layer 184 and thestorage sealing member 140. The method may further include: positioning theabsorbent layer 184 on theexterior facing side 34 of the interface dressing 20; and covering theabsorbent layer 184 with thestorage sealing member 140 to provide the sealedstorage space 174 between thestorage sealing member 140 and theexterior facing side 34 of the interface dressing 20. - In some embodiments, the storage dressing 124 may include the
absorbent layer 184 and thestorage sealing member 140. The method may further include: positioning theabsorbent layer 184 on theexterior facing side 34 of theinterface sealing member 24 in fluid communication with theaperture 38 in theinterface sealing member 24; and covering theabsorbent layer 184 with thestorage sealing member 140 to provide the sealedstorage space 174 between thestorage sealing member 140 and theexterior facing side 34 of theinterface sealing member 24. - Although this specification discloses advantages in the context of certain illustrative, non-limiting embodiments, various changes, substitutions, permutations, and alterations may be made without departing from the scope of the appended claims. Further, any feature described in connection with any one embodiment may also be applicable to any other embodiment.
Claims (31)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/528,441 US20190351111A1 (en) | 2014-05-02 | 2019-07-31 | Fluid storage devices, systems, and methods |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461988076P | 2014-05-02 | 2014-05-02 | |
PCT/US2015/029037 WO2015168681A1 (en) | 2014-05-02 | 2015-05-04 | Fluid storage devices, systems, and methods |
US201615307472A | 2016-10-28 | 2016-10-28 | |
US16/528,441 US20190351111A1 (en) | 2014-05-02 | 2019-07-31 | Fluid storage devices, systems, and methods |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/307,472 Division US10406266B2 (en) | 2014-05-02 | 2015-05-04 | Fluid storage devices, systems, and methods |
PCT/US2015/029037 Division WO2015168681A1 (en) | 2014-05-02 | 2015-05-04 | Fluid storage devices, systems, and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
US20190351111A1 true US20190351111A1 (en) | 2019-11-21 |
Family
ID=54359420
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/307,472 Active 2035-08-18 US10406266B2 (en) | 2014-05-02 | 2015-05-04 | Fluid storage devices, systems, and methods |
US16/528,441 Abandoned US20190351111A1 (en) | 2014-05-02 | 2019-07-31 | Fluid storage devices, systems, and methods |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/307,472 Active 2035-08-18 US10406266B2 (en) | 2014-05-02 | 2015-05-04 | Fluid storage devices, systems, and methods |
Country Status (3)
Country | Link |
---|---|
US (2) | US10406266B2 (en) |
EP (1) | EP3137029B1 (en) |
WO (1) | WO2015168681A1 (en) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10968543B2 (en) | 2011-12-01 | 2021-04-06 | Convatec Technologies Inc. | Wound dressing for use in vacuum therapy |
US11116884B2 (en) | 2010-12-08 | 2021-09-14 | Convatec Technologies Inc. | Integrated system for assessing wound exudates |
US11135315B2 (en) | 2010-11-30 | 2021-10-05 | Convatec Technologies Inc. | Composition for detecting biofilms on viable tissues |
US11241339B2 (en) | 2011-11-29 | 2022-02-08 | Convatec Inc. | Perforated binder for laminated wound dressing |
US11241525B2 (en) | 2010-12-08 | 2022-02-08 | Convatec Technologies Inc. | Wound exudate monitor accessory |
US11266774B2 (en) | 2016-07-08 | 2022-03-08 | Convatec Technologies Inc. | Fluid collection apparatus |
US11286601B2 (en) | 2012-12-20 | 2022-03-29 | Convatec Technologies, Inc. | Processing of chemically modified cellulosic fibres |
US11331221B2 (en) | 2019-12-27 | 2022-05-17 | Convatec Limited | Negative pressure wound dressing |
US11452808B2 (en) | 2016-07-08 | 2022-09-27 | Convatec Technologies Inc. | Fluid flow sensing |
US11458044B2 (en) | 2008-09-29 | 2022-10-04 | Convatec Technologies Inc. | Wound dressing |
US11583430B2 (en) | 2011-09-02 | 2023-02-21 | Convatec Ltd. | Skin contact material |
US11596554B2 (en) | 2016-07-08 | 2023-03-07 | Convatec Technologies Inc. | Flexible negative pressure system |
US11628093B2 (en) | 2008-05-08 | 2023-04-18 | Convatec Technologies, Inc. | Wound dressing |
US11723808B2 (en) | 2016-03-30 | 2023-08-15 | Convatec Technologies Inc. | Detecting microbial infections in wounds |
US11740241B2 (en) | 2016-03-30 | 2023-08-29 | Synovo Gmbh | Construct including an anchor, an enzyme recognition site and an indicator region for detecting microbial infection in wounds |
US11771819B2 (en) | 2019-12-27 | 2023-10-03 | Convatec Limited | Low profile filter devices suitable for use in negative pressure wound therapy systems |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013066426A2 (en) | 2011-06-24 | 2013-05-10 | Kci Licensing, Inc. | Reduced-pressure dressings employing tissue-fixation elements |
CA3065381A1 (en) | 2017-06-07 | 2018-12-13 | Kci Licensing, Inc. | Tissue contact interface |
WO2018226687A1 (en) | 2017-06-07 | 2018-12-13 | Kci Licensing, Inc. | Methods for manufacturing and assembling dual material tissue interface for negative-pressure therapy |
CN110799222B (en) | 2017-06-07 | 2023-03-07 | 3M创新知识产权公司 | Systems, devices, and methods for negative pressure therapy to reduce tissue ingrowth |
CN110831552B (en) | 2017-06-07 | 2022-06-10 | 3M创新知识产权公司 | Multilayered wound filler with extended wear time |
EP3634337B1 (en) | 2017-06-07 | 2023-05-24 | 3M Innovative Properties Company | Methods for manufacturing and assembling dual material tissue interface for negative-pressure therapy |
JP2020523077A (en) | 2017-06-07 | 2020-08-06 | ケーシーアイ ライセンシング インコーポレイテッド | Composite dressing for promoting granulation and reducing maceration by negative pressure treatment |
JP7204685B2 (en) | 2017-06-07 | 2023-01-16 | スリーエム イノベイティブ プロパティズ カンパニー | A composite dressing that promotes granulation formation and reduces maceration in negative pressure therapy |
US11471584B2 (en) | 2017-06-07 | 2022-10-18 | Kci Licensing, Inc. | Composite dressings for improved granulation and reduced maceration with negative-pressure treatment |
WO2018226631A1 (en) * | 2017-06-07 | 2018-12-13 | Kci Licensing, Inc. | Peel and place dressing for thick exudate and instillation |
CN110799157B (en) | 2017-06-07 | 2022-07-01 | 3M创新知识产权公司 | Assembly features and methods for peel and place dressing for use with negative pressure therapy |
WO2019089118A1 (en) * | 2017-10-30 | 2019-05-09 | Kci Licensing, Inc. | Systems, apparatuses, and methods for negative-pressure treatment with pressure delivery indication |
US20200085632A1 (en) * | 2018-09-17 | 2020-03-19 | Kci Licensing, Inc. | Absorbent negative pressure dressing |
WO2020251703A1 (en) * | 2019-06-12 | 2020-12-17 | Kci Licensing, Inc. | Composite dressing for tissue closure with negative pressure |
TWI690785B (en) * | 2019-08-29 | 2020-04-11 | 榮美創意科技股份有限公司 | Make up fluid management and supply device and method |
WO2021094946A1 (en) * | 2019-11-11 | 2021-05-20 | Kci Licensing, Inc. | Wound sealing film |
US20220032050A1 (en) * | 2020-07-30 | 2022-02-03 | Biboting International Co., Ltd. | Facial beautifying and care apparatus |
Family Cites Families (447)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3172808A (en) | 1965-03-09 | Method of treating wounds | ||
US1355846A (en) | 1920-02-06 | 1920-10-19 | David A Rannells | Medical appliance |
US1944834A (en) | 1932-01-16 | 1934-01-23 | Johnson & Johnson | Adhesive tape or plaster |
US2552664A (en) | 1947-04-24 | 1951-05-15 | Bertha W Burdine | Adhesive material |
US2547758A (en) | 1949-01-05 | 1951-04-03 | Wilmer B Keeling | Instrument for treating the male urethra |
US2632443A (en) | 1949-04-18 | 1953-03-24 | Eleanor P Lesher | Surgical dressing |
GB692578A (en) | 1949-09-13 | 1953-06-10 | Minnesota Mining & Mfg | Improvements in or relating to drape sheets for surgical use |
US2682873A (en) | 1952-07-30 | 1954-07-06 | Johnson & Johnson | General purpose protective dressing |
NL189176B (en) | 1956-07-13 | 1900-01-01 | Hisamitsu Pharmaceutical Co | PLASTER BASED ON A SYNTHETIC RUBBER. |
US2860081A (en) | 1954-11-22 | 1958-11-11 | Bert M Eiken | Trouser cuff tack |
US2969057A (en) | 1957-11-04 | 1961-01-24 | Brady Co W H | Nematodic swab |
US3183116A (en) | 1960-03-14 | 1965-05-11 | Kendall & Co | Method of making perforated adhesive tapes |
US3066672A (en) | 1960-09-27 | 1962-12-04 | Jr William H Crosby | Method and apparatus for serial sampling of intestinal juice |
GB1052614A (en) | 1964-06-04 | |||
US3367332A (en) | 1965-08-27 | 1968-02-06 | Gen Electric | Product and process for establishing a sterile area of skin |
US3520300A (en) | 1967-03-15 | 1970-07-14 | Amp Inc | Surgical sponge and suction device |
US3777016A (en) | 1967-10-31 | 1973-12-04 | J Gilbert | Composition and method for the treat-ment of damaged skin |
US3568675A (en) | 1968-08-30 | 1971-03-09 | Clyde B Harvey | Fistula and penetrating wound dressing |
US4141361A (en) | 1970-02-09 | 1979-02-27 | Snyder Manufacturing Co., Incorporated | Evacuator |
US3682180A (en) | 1970-06-08 | 1972-08-08 | Coilform Co Inc | Drain clip for surgical drain |
BE789293Q (en) | 1970-12-07 | 1973-01-15 | Parke Davis & Co | MEDICO-SURGICAL DRESSING FOR BURNS AND SIMILAR LESIONS |
US3742952A (en) | 1971-04-28 | 1973-07-03 | Alpha Ind Inc | Surgical suction pump assembly |
US3779243A (en) | 1971-10-15 | 1973-12-18 | J Tussey | Contamination free surgical evacuator |
GB1386800A (en) | 1971-10-27 | 1975-03-12 | Johnson & Johnson | Self-adhesive disposable surgical drape |
US3852823A (en) | 1972-03-08 | 1974-12-10 | J Jones | Method of sealing a bathing or shower cap to the head of the wearer |
US3774611A (en) | 1972-06-08 | 1973-11-27 | J Tussey | Stabilized contamination free surgical evacuator |
US3983297A (en) | 1972-06-14 | 1976-09-28 | Teijin Limited | Pressure-sensitive adhesive tape or drape |
US3826254A (en) | 1973-02-26 | 1974-07-30 | Verco Ind | Needle or catheter retaining appliance |
US3903882A (en) | 1974-04-19 | 1975-09-09 | American Cyanamid Co | Composite dressing |
US3967624A (en) | 1975-04-04 | 1976-07-06 | Johnson & Johnson | Disposable diaper with tab fasteners having a perforated cover strip |
DE2527706A1 (en) | 1975-06-21 | 1976-12-30 | Hanfried Dr Med Weigand | DEVICE FOR THE INTRODUCTION OF CONTRAST AGENTS INTO AN ARTIFICIAL INTESTINAL OUTLET |
US4060081A (en) | 1975-07-15 | 1977-11-29 | Massachusetts Institute Of Technology | Multilayer membrane useful as synthetic skin |
GB1563695A (en) | 1975-07-29 | 1980-03-26 | Smith & Nephew Res | Adhesive material |
DE2640413C3 (en) | 1976-09-08 | 1980-03-27 | Richard Wolf Gmbh, 7134 Knittlingen | Catheter monitor |
NL7710909A (en) | 1976-10-08 | 1978-04-11 | Smith & Nephew | COMPOSITE STRAPS. |
GB1562244A (en) | 1976-11-11 | 1980-03-05 | Lock P M | Wound dressing materials |
US4080970A (en) | 1976-11-17 | 1978-03-28 | Miller Thomas J | Post-operative combination dressing and internal drain tube with external shield and tube connector |
US4139004A (en) | 1977-02-17 | 1979-02-13 | Gonzalez Jr Harry | Bandage apparatus for treating burns |
US4184510A (en) | 1977-03-15 | 1980-01-22 | Fibra-Sonics, Inc. | Valued device for controlling vacuum in surgery |
US4165748A (en) | 1977-11-07 | 1979-08-28 | Johnson Melissa C | Catheter tube holder |
US4245637A (en) | 1978-07-10 | 1981-01-20 | Nichols Robert L | Shutoff valve sleeve |
SE414994B (en) | 1978-11-28 | 1980-09-01 | Landstingens Inkopscentral | VENKATETERFORBAND |
WO1980001139A1 (en) | 1978-12-06 | 1980-06-12 | Svedman Paul | Device for treating tissues,for example skin |
US4266545A (en) | 1979-04-06 | 1981-05-12 | Moss James P | Portable suction device for collecting fluids from a closed wound |
US4284079A (en) | 1979-06-28 | 1981-08-18 | Adair Edwin Lloyd | Method for applying a male incontinence device |
US4261363A (en) | 1979-11-09 | 1981-04-14 | C. R. Bard, Inc. | Retention clips for body fluid drains |
US4569348A (en) | 1980-02-22 | 1986-02-11 | Velcro Usa Inc. | Catheter tube holder strap |
EP0035583B1 (en) | 1980-03-11 | 1985-08-14 | Schmid, Eduard, Dr.Dr.med. | Skin graft pressure bandage |
US5445604A (en) | 1980-05-22 | 1995-08-29 | Smith & Nephew Associated Companies, Ltd. | Wound dressing with conformable elastomeric wound contact layer |
US4297995A (en) | 1980-06-03 | 1981-11-03 | Key Pharmaceuticals, Inc. | Bandage containing attachment post |
US4529402A (en) | 1980-07-08 | 1985-07-16 | Snyder Laboratories, Inc. | Closed wound suction evacuator with rotary valve |
NZ197782A (en) | 1980-07-30 | 1985-07-31 | Smith & Nephew Ass | A moisture vapour transmitting elastic bandage |
US4333468A (en) | 1980-08-18 | 1982-06-08 | Geist Robert W | Mesentery tube holder apparatus |
US4995382A (en) | 1981-02-13 | 1991-02-26 | Smith And Nephew Associated Companies Limited | Wound dressing, manufacture and use |
US4465485A (en) | 1981-03-06 | 1984-08-14 | Becton, Dickinson And Company | Suction canister with unitary shut-off valve and filter features |
US4392853A (en) | 1981-03-16 | 1983-07-12 | Rudolph Muto | Sterile assembly for protecting and fastening an indwelling device |
JPS57156403A (en) | 1981-03-24 | 1982-09-27 | Shin Etsu Chem Co Ltd | Gradual vapor releaser with good shaping property |
US4360015A (en) | 1981-05-14 | 1982-11-23 | Hartford Corporation | Multilayer absorbent structure |
US4373519A (en) | 1981-06-26 | 1983-02-15 | Minnesota Mining And Manufacturing Company | Composite wound dressing |
US4392858A (en) | 1981-07-16 | 1983-07-12 | Sherwood Medical Company | Wound drainage device |
US4419097A (en) | 1981-07-31 | 1983-12-06 | Rexar Industries, Inc. | Attachment for catheter tube |
AU550575B2 (en) | 1981-08-07 | 1986-03-27 | Richard Christian Wright | Wound drainage device |
SE429197B (en) | 1981-10-14 | 1983-08-22 | Frese Nielsen | SAR TREATMENT DEVICE |
DE3146266A1 (en) | 1981-11-21 | 1983-06-01 | B. Braun Melsungen Ag, 3508 Melsungen | COMBINED DEVICE FOR A MEDICAL SUCTION DRAINAGE |
US4551139A (en) | 1982-02-08 | 1985-11-05 | Marion Laboratories, Inc. | Method and apparatus for burn wound treatment |
US4475909A (en) | 1982-05-06 | 1984-10-09 | Eisenberg Melvin I | Male urinary device and method for applying the device |
EP0097517B1 (en) | 1982-06-22 | 1987-06-24 | Smith and Nephew Associated Companies p.l.c. | Wound dressing, manufacture and use |
EP0100148B1 (en) | 1982-07-06 | 1986-01-08 | Dow Corning Limited | Medical-surgical dressing and a process for the production thereof |
NZ206837A (en) | 1983-01-27 | 1986-08-08 | Johnson & Johnson Prod Inc | Thin film adhesive dressing:backing material in three sections |
US4548202A (en) | 1983-06-20 | 1985-10-22 | Ethicon, Inc. | Mesh tissue fasteners |
US4540412A (en) | 1983-07-14 | 1985-09-10 | The Kendall Company | Device for moist heat therapy |
US4543100A (en) | 1983-11-01 | 1985-09-24 | Brodsky Stuart A | Catheter and drain tube retainer |
GB8334484D0 (en) | 1983-12-24 | 1984-02-01 | Smith & Nephew Ass | Surgical dressing |
US4525374A (en) | 1984-02-27 | 1985-06-25 | Manresa, Inc. | Treating hydrophobic filters to render them hydrophilic |
GB2157958A (en) | 1984-05-03 | 1985-11-06 | Ernest Edward Austen Bedding | Ball game net support |
US4897081A (en) | 1984-05-25 | 1990-01-30 | Thermedics Inc. | Percutaneous access device |
US5215522A (en) | 1984-07-23 | 1993-06-01 | Ballard Medical Products | Single use medical aspirating device and method |
GB8419745D0 (en) | 1984-08-02 | 1984-09-05 | Smith & Nephew Ass | Wound dressing |
US4872450A (en) | 1984-08-17 | 1989-10-10 | Austad Eric D | Wound dressing and method of forming same |
US4655754A (en) | 1984-11-09 | 1987-04-07 | Stryker Corporation | Vacuum wound drainage system and lipids baffle therefor |
US4826494A (en) | 1984-11-09 | 1989-05-02 | Stryker Corporation | Vacuum wound drainage system |
US4605399A (en) | 1984-12-04 | 1986-08-12 | Complex, Inc. | Transdermal infusion device |
US4664652A (en) | 1985-02-07 | 1987-05-12 | Snyder Laboratories, Inc. | Wound evacuator |
GB8509977D0 (en) | 1985-04-18 | 1985-05-30 | Juhasz L | Wound dressings |
US5037397A (en) | 1985-05-03 | 1991-08-06 | Medical Distributors, Inc. | Universal clamp |
GB2176401A (en) | 1985-06-12 | 1986-12-31 | Vernon Carus Ltd | Wound dressing |
US4640688A (en) | 1985-08-23 | 1987-02-03 | Mentor Corporation | Urine collection catheter |
US4710165A (en) | 1985-09-16 | 1987-12-01 | Mcneil Charles B | Wearable, variable rate suction/collection device |
US4758220A (en) | 1985-09-26 | 1988-07-19 | Alcon Laboratories, Inc. | Surgical cassette proximity sensing and latching apparatus |
US4871611A (en) | 1985-11-15 | 1989-10-03 | Mead Release Products, Inc. | Breathable backing or release liner and process for forming the same |
US4733659A (en) | 1986-01-17 | 1988-03-29 | Seton Company | Foam bandage |
WO1987004626A1 (en) | 1986-01-31 | 1987-08-13 | Osmond, Roger, L., W. | Suction system for wound and gastro-intestinal drainage |
JPS62139523U (en) | 1986-02-14 | 1987-09-03 | ||
US4838883A (en) | 1986-03-07 | 1989-06-13 | Nissho Corporation | Urine-collecting device |
GB2192142B (en) | 1986-07-04 | 1990-11-28 | Johnson & Johnson | Wound dressing |
DE3778195D1 (en) | 1986-04-07 | 1992-05-21 | Agency Ind Science Techn | ANTITHROMOGENIC MATERIAL. |
JPS62275456A (en) | 1986-05-22 | 1987-11-30 | 帝三製薬株式会社 | Wound protective material |
DE3772453D1 (en) | 1986-05-28 | 1991-10-02 | Lohmann Therapie Syst Lts | FIXING SYSTEM FOR FASTENING CATHETERS, CANNULA OR THE LIKE ON THE SKIN SURFACE. |
JPS62281965A (en) | 1986-05-29 | 1987-12-07 | テルモ株式会社 | Catheter and catheter fixing member |
US5025783A (en) | 1986-09-02 | 1991-06-25 | Sparta Surgical Corp. | Method of applying a medical dressing device |
GB8621884D0 (en) | 1986-09-11 | 1986-10-15 | Bard Ltd | Catheter applicator |
GB2195255B (en) | 1986-09-30 | 1991-05-01 | Vacutec Uk Limited | Apparatus for vacuum treatment of an epidermal surface |
US4743232A (en) | 1986-10-06 | 1988-05-10 | The Clinipad Corporation | Package assembly for plastic film bandage |
DE3634569A1 (en) | 1986-10-10 | 1988-04-21 | Sachse Hans E | CONDOM CATHETER, A URINE TUBE CATHETER FOR PREVENTING RISING INFECTIONS |
NL8602662A (en) | 1986-10-23 | 1988-05-16 | Patentico Ltd | COVER PLATE TO BE ADAPTED. |
JPS63135179A (en) | 1986-11-26 | 1988-06-07 | 立花 俊郎 | Subcataneous drug administration set |
GB8628564D0 (en) | 1986-11-28 | 1987-01-07 | Smiths Industries Plc | Anti-foaming agent suction apparatus |
US4867150A (en) | 1987-01-20 | 1989-09-19 | The B. F. Goodrich Company | Perforated elastomeric soft film and wound dressing made therewith |
CN87101823B (en) | 1987-03-12 | 1988-10-05 | 铁汉 | Medical dressing materials without adhesion |
GB8706116D0 (en) | 1987-03-14 | 1987-04-15 | Smith & Nephew Ass | Adhesive dressings |
US4787888A (en) | 1987-06-01 | 1988-11-29 | University Of Connecticut | Disposable piezoelectric polymer bandage for percutaneous delivery of drugs and method for such percutaneous delivery (a) |
US5356386A (en) | 1987-06-05 | 1994-10-18 | Uresil Corporation | Apparatus for locating body cavities |
US4863449A (en) | 1987-07-06 | 1989-09-05 | Hollister Incorporated | Adhesive-lined elastic condom cathether |
US4930997A (en) | 1987-08-19 | 1990-06-05 | Bennett Alan N | Portable medical suction device |
US5176663A (en) | 1987-12-02 | 1993-01-05 | Pal Svedman | Dressing having pad with compressibility limiting elements |
US5018515A (en) | 1987-12-14 | 1991-05-28 | The Kendall Company | See through absorbent dressing |
US4906240A (en) | 1988-02-01 | 1990-03-06 | Matrix Medica, Inc. | Adhesive-faced porous absorbent sheet and method of making same |
US4832008A (en) | 1988-02-09 | 1989-05-23 | The Kendall Company | Wound dressing with release sheets strip |
US4981474A (en) | 1988-02-16 | 1991-01-01 | Baxter Travenol Laboratories, Inc. | Body fluid drainage device |
US4985019A (en) | 1988-03-11 | 1991-01-15 | Michelson Gary K | X-ray marker |
GB8812096D0 (en) | 1988-05-21 | 1988-06-22 | Smith & Nephew Ass | Adhesive sheet |
GB8812803D0 (en) | 1988-05-28 | 1988-06-29 | Smiths Industries Plc | Medico-surgical containers |
US5374261A (en) | 1990-07-24 | 1994-12-20 | Yoon; Inbae | Multifunctional devices for use in endoscopic surgical procedures and methods-therefor |
US4919654A (en) | 1988-08-03 | 1990-04-24 | Kalt Medical Corporation | IV clamp with membrane |
US5000741A (en) | 1988-08-22 | 1991-03-19 | Kalt Medical Corporation | Transparent tracheostomy tube dressing |
JPH046760Y2 (en) | 1988-12-27 | 1992-02-24 | ||
EP0379416B1 (en) | 1989-01-16 | 1995-03-08 | Roussel-Uclaf | Azabicycloheptene derivatives and their salts, process for their preparation, their use as medicaments and compositions containing them |
GB8906100D0 (en) | 1989-03-16 | 1989-04-26 | Smith & Nephew | Laminates |
US5100396A (en) | 1989-04-03 | 1992-03-31 | Zamierowski David S | Fluidic connection system and method |
US5527293A (en) | 1989-04-03 | 1996-06-18 | Kinetic Concepts, Inc. | Fastening system and method |
US5261893A (en) | 1989-04-03 | 1993-11-16 | Zamierowski David S | Fastening system and method |
US4969880A (en) | 1989-04-03 | 1990-11-13 | Zamierowski David S | Wound dressing and treatment method |
US5266372A (en) | 1989-04-24 | 1993-11-30 | Nitto Denko Corporation | Fixing tape |
JP2719671B2 (en) | 1989-07-11 | 1998-02-25 | 日本ゼオン株式会社 | Wound dressing |
US5358494A (en) | 1989-07-11 | 1994-10-25 | Svedman Paul | Irrigation dressing |
US5232453A (en) | 1989-07-14 | 1993-08-03 | E. R. Squibb & Sons, Inc. | Catheter holder |
GB2235877A (en) | 1989-09-18 | 1991-03-20 | Antonio Talluri | Closed wound suction apparatus |
US5152757A (en) | 1989-12-14 | 1992-10-06 | Brigham And Women's Hospital | System for diagnosis and treatment of wounds |
US5423778A (en) | 1989-12-14 | 1995-06-13 | Elof Eriksson | System and method for transplantation of cells |
US5270358A (en) | 1989-12-28 | 1993-12-14 | Minnesota Mining And Manufacturing Company | Composite of a disperesed gel in an adhesive matrix |
US6680113B1 (en) | 1989-12-29 | 2004-01-20 | 3M Innovative Properties Company | Multi-layered dressing |
US5112323A (en) | 1990-02-08 | 1992-05-12 | Snyder Laboratories, Inc. | Wound evacuator |
US5134994A (en) | 1990-02-12 | 1992-08-04 | Say Sam L | Field aspirator in a soft pack with externally mounted container |
US4996128A (en) | 1990-03-12 | 1991-02-26 | Nova Manufacturing, Inc. | Rechargeable battery |
US5092858A (en) | 1990-03-20 | 1992-03-03 | Becton, Dickinson And Company | Liquid gelling agent distributor device |
US5092323A (en) | 1990-06-29 | 1992-03-03 | Hollister Incorporated | Moisture-absorbing, site-revealing adhesive dressing |
US5151314A (en) | 1991-01-31 | 1992-09-29 | Johnson & Johnson Medical, Inc. | Three-layer laminated panel |
AU641580B2 (en) | 1991-02-28 | 1993-09-23 | National Starch And Chemical Investment Holding Corporation | Water vapor permeable pressure sensitive adhesive composition |
US5180375A (en) | 1991-05-02 | 1993-01-19 | Feibus Miriam H | Woven surgical drain and woven surgical sponge |
US5149331A (en) | 1991-05-03 | 1992-09-22 | Ariel Ferdman | Method and device for wound closure |
US5653224A (en) | 1991-06-10 | 1997-08-05 | Creative Integration & Design, Inc. | Nasal dilator with areas of adhesive engagement of varying strength |
CA2071391C (en) | 1991-07-29 | 1998-05-05 | Thomas H. Gilman | Vented wound dressing |
US5387207A (en) | 1991-08-12 | 1995-02-07 | The Procter & Gamble Company | Thin-unit-wet absorbent foam materials for aqueous body fluids and process for making same |
SE502780C2 (en) | 1991-09-25 | 1996-01-08 | Siemens Elema Ab | dehumidifying device |
US5342329A (en) | 1991-10-11 | 1994-08-30 | Inmed Ltda. | Portable disposable device for post-surgical suction |
US5278100A (en) | 1991-11-08 | 1994-01-11 | Micron Technology, Inc. | Chemical vapor deposition technique for depositing titanium silicide on semiconductor wafers |
US5636643A (en) | 1991-11-14 | 1997-06-10 | Wake Forest University | Wound treatment employing reduced pressure |
US5645081A (en) | 1991-11-14 | 1997-07-08 | Wake Forest University | Method of treating tissue damage and apparatus for same |
US5279550A (en) | 1991-12-19 | 1994-01-18 | Gish Biomedical, Inc. | Orthopedic autotransfusion system |
US5585178A (en) | 1991-12-31 | 1996-12-17 | Minnesota Mining & Manufacturing Company | Composite adhesive tape |
US5246775A (en) | 1992-01-03 | 1993-09-21 | Loscuito Salvatore M | Self-sticking drywall tape |
AU4102493A (en) | 1992-03-16 | 1994-11-08 | Envirosurgical, Inc. | Surgery plume filter device and method of filtering |
US5167613A (en) | 1992-03-23 | 1992-12-01 | The Kendall Company | Composite vented wound dressing |
SE500973C2 (en) | 1992-03-30 | 1994-10-10 | Moelnlycke Ab | Absorbent wound dressing |
FR2690617B1 (en) | 1992-04-29 | 1994-06-24 | Cbh Textile | TRANSPARENT ADHESIVE DRESSING. |
US5678564A (en) | 1992-08-07 | 1997-10-21 | Bristol Myers Squibb | Liquid removal system |
US5419769A (en) | 1992-10-23 | 1995-05-30 | Smiths Industries Medical Systems, Inc. | Suction systems |
GB2272645B8 (en) * | 1992-11-23 | 2010-02-10 | Johnson & Johnson Medical | Wound dressing |
US5429590A (en) | 1992-12-01 | 1995-07-04 | Nitto Denko Corporation | Medical water-absorptive polymer and dressing for wound and medical bandage using the same |
DK169711B1 (en) | 1993-01-15 | 1995-01-23 | Coloplast As | A dressing |
DE4306478A1 (en) | 1993-03-02 | 1994-09-08 | Wolfgang Dr Wagner | Drainage device, in particular pleural drainage device, and drainage method |
DE4308649C2 (en) | 1993-03-18 | 1995-11-16 | Lohmann Gmbh & Co Kg | Medical plaster material and process for its production and its use |
US5342376A (en) | 1993-05-03 | 1994-08-30 | Dermagraphics, Inc. | Inserting device for a barbed tissue connector |
US6241747B1 (en) | 1993-05-03 | 2001-06-05 | Quill Medical, Inc. | Barbed Bodily tissue connector |
AU667766B2 (en) | 1993-05-27 | 1996-04-04 | Paul Hartmann Ag | Hydrogel wound dressing product |
US5344415A (en) | 1993-06-15 | 1994-09-06 | Deroyal Industries, Inc. | Sterile system for dressing vascular access site |
IE69360B1 (en) | 1993-07-01 | 1996-09-04 | Abbott Lab | Gelling treatment for suction drainage system |
US5458938A (en) | 1993-08-03 | 1995-10-17 | Minnesota Mining And Manufacturing Company | Mounting laminate having recessed adhesive areas |
US5437651A (en) | 1993-09-01 | 1995-08-01 | Research Medical, Inc. | Medical suction apparatus |
US5447492A (en) | 1993-12-20 | 1995-09-05 | New Dimensions In Medicine, Inc. | External fixation dressing for accommodating a retaining pin |
US5549584A (en) | 1994-02-14 | 1996-08-27 | The Kendall Company | Apparatus for removing fluid from a wound |
DE4406158A1 (en) | 1994-02-25 | 1995-08-31 | Rhein Chemie Rheinau Gmbh | Polyurethane elastomers with reduced gas permeability |
US5807295A (en) | 1994-03-30 | 1998-09-15 | Smith & Nephew Plc | Medical articles |
GB2288162B (en) | 1994-03-30 | 1997-11-26 | Harrison & Sons Ltd | Self-adhesive stamps |
US6086995A (en) | 1994-05-13 | 2000-07-11 | Decora North America | Self-wound self-adhesive surface covering material |
US5607388A (en) | 1994-06-16 | 1997-03-04 | Hercules Incorporated | Multi-purpose wound dressing |
US5556375A (en) | 1994-06-16 | 1996-09-17 | Hercules Incorporated | Wound dressing having a fenestrated base layer |
US5664270A (en) | 1994-07-19 | 1997-09-09 | Kinetic Concepts, Inc. | Patient interface system |
ATE270561T1 (en) | 1994-08-22 | 2004-07-15 | Kinetic Concepts Inc | CANISTER |
US6228873B1 (en) | 1994-12-09 | 2001-05-08 | The Regents Of The University Of California | Method for enhancing outflow of aqueous humor in treatment of glaucoma |
SE503779C2 (en) | 1994-12-30 | 1996-09-02 | Moelnlycke Ab | Absorbent articles, comprising a receiving space in a storage layer, which upon wetting increases in extent perpendicular to the surface of the article and absorbent body |
US5998692A (en) | 1995-01-26 | 1999-12-07 | Innovative Technologies Limited | Wound dressing |
DE29504378U1 (en) | 1995-03-15 | 1995-09-14 | MTG Medizinisch, technische Gerätebau GmbH, 66299 Friedrichsthal | Electronically controlled low-vacuum pump for chest and wound drainage |
US5634893A (en) | 1995-04-24 | 1997-06-03 | Haemonetics Corporation | Autotransfusion apparatus |
US5611373A (en) | 1995-04-27 | 1997-03-18 | Handy & Harman Automotive Group, Inc. | Laminated fuel line and connector |
DE19517699C2 (en) | 1995-05-13 | 1999-11-04 | Wilhelm Fleischmann | Device for vacuum sealing a wound |
GB9523253D0 (en) | 1995-11-14 | 1996-01-17 | Mediscus Prod Ltd | Portable wound treatment apparatus |
US5736470A (en) | 1996-06-25 | 1998-04-07 | Omega Research, Inc. | Pressure sensitive adhesive article and method of making |
US5776119A (en) | 1996-09-30 | 1998-07-07 | Bilbo; Sharon C. | Portable suction unit |
GB9701178D0 (en) | 1997-01-21 | 1997-03-12 | Smith & Nephew | Dressings |
US5998561A (en) | 1997-03-11 | 1999-12-07 | Jeneric/Pentron Incorporated | Catalyst and composition for silicone dental impression materials |
GB2324732B (en) | 1997-05-02 | 2001-09-26 | Johnson & Johnson Medical | Absorbent wound dressings |
US5878971A (en) | 1997-05-22 | 1999-03-09 | Minnesota Mining And Manufacturing Company | Perforated tab and tabbed tape rolls |
NL1006457C2 (en) | 1997-07-03 | 1999-01-05 | Polymedics N V | Drainage system to be used with an open wound, element used for applying a drainage pipe or hose and method for applying the drainage system. |
US6135116A (en) | 1997-07-28 | 2000-10-24 | Kci Licensing, Inc. | Therapeutic method for treating ulcers |
US6420622B1 (en) | 1997-08-01 | 2002-07-16 | 3M Innovative Properties Company | Medical article having fluid control film |
US6290685B1 (en) | 1998-06-18 | 2001-09-18 | 3M Innovative Properties Company | Microchanneled active fluid transport devices |
AU755496B2 (en) | 1997-09-12 | 2002-12-12 | Kci Licensing, Inc. | Surgical drape and suction head for wound treatment |
GB9719520D0 (en) | 1997-09-12 | 1997-11-19 | Kci Medical Ltd | Surgical drape and suction heads for wound treatment |
US5919476A (en) | 1997-09-29 | 1999-07-06 | Pmt Corporation | Reinforced gel sheeting for scar treatment |
US6972141B1 (en) | 1997-12-12 | 2005-12-06 | 3M Innovative Properties Company | Removable adhesive tape laminate and separable fastener |
US5964252A (en) | 1997-12-18 | 1999-10-12 | Morgan Adhesives Company | Adhesive closure system with an abridged release liner |
US6071267A (en) | 1998-02-06 | 2000-06-06 | Kinetic Concepts, Inc. | Medical patient fluid management interface system and method |
US6458109B1 (en) | 1998-08-07 | 2002-10-01 | Hill-Rom Services, Inc. | Wound treatment apparatus |
US20030225355A1 (en) | 1998-10-01 | 2003-12-04 | Butler Charles E. | Composite material for wound repair |
DE69905059T2 (en) | 1998-10-02 | 2003-11-20 | 3M Innovative Properties Co | ELASTIC COMPOSITES |
US6488643B1 (en) | 1998-10-08 | 2002-12-03 | Kci Licensing, Inc. | Wound healing foot wrap |
US6736270B2 (en) | 1998-10-30 | 2004-05-18 | Varco I/P, Inc. | Glued screens for shale shakers |
ES2219841T3 (en) | 1998-11-19 | 2004-12-01 | Minnesota Mining And Manufacturing Company | ADHESIVE TAPE FOR A diaper closure system. |
US6627215B1 (en) | 1998-12-30 | 2003-09-30 | Oligos Etc. Inc. | Devices for improved wound management |
GB2348136B (en) | 1999-03-24 | 2003-06-04 | Johnson & Johnson Medical Ltd | Wound dressings having low adherency |
US6287316B1 (en) | 1999-03-26 | 2001-09-11 | Ethicon, Inc. | Knitted surgical mesh |
US7799004B2 (en) | 2001-03-05 | 2010-09-21 | Kci Licensing, Inc. | Negative pressure wound treatment apparatus and infection identification system and method |
US6856821B2 (en) | 2000-05-26 | 2005-02-15 | Kci Licensing, Inc. | System for combined transcutaneous blood gas monitoring and vacuum assisted wound closure |
US6695823B1 (en) | 1999-04-09 | 2004-02-24 | Kci Licensing, Inc. | Wound therapy device |
US6991643B2 (en) | 2000-12-20 | 2006-01-31 | Usgi Medical Inc. | Multi-barbed device for retaining tissue in apposition and methods of use |
US6238762B1 (en) | 1999-09-03 | 2001-05-29 | Kittrich Corpn | Selectively tearable covering sheet |
US6495229B1 (en) | 1999-09-17 | 2002-12-17 | Avery Dennison Corporation | Pattern coated adhesive article |
US6638605B1 (en) | 1999-11-16 | 2003-10-28 | Allegiance Corporation | Intermittently bonded nonwoven disposable surgical laminates |
US6755807B2 (en) | 1999-11-29 | 2004-06-29 | Hill-Rom Services, Inc. | Wound treatment apparatus |
US6764462B2 (en) | 2000-11-29 | 2004-07-20 | Hill-Rom Services Inc. | Wound treatment apparatus |
JP4330751B2 (en) | 2000-02-14 | 2009-09-16 | 富士フイルム株式会社 | Radiographic image acquisition method and apparatus, and cell interval detection method and apparatus therefor |
US6566575B1 (en) | 2000-02-15 | 2003-05-20 | 3M Innovative Properties Company | Patterned absorbent article for wound dressing |
US6548727B1 (en) | 2000-02-17 | 2003-04-15 | 3M Innovative Properties Company | Foam/film composite medical articles |
ATE266443T1 (en) | 2000-02-24 | 2004-05-15 | Venetec Int Inc | UNIVERSAL CATHETER FASTENING SYSTEM |
EP1267767B1 (en) | 2000-03-10 | 2006-03-01 | 3M Innovative Properties Company | Medical dressings with multiple adhesives and methods of manufacturing |
AU4748901A (en) | 2000-03-21 | 2001-10-03 | Kimberly Clark Co | Permanently wettable superabsorbents |
GB0011202D0 (en) | 2000-05-09 | 2000-06-28 | Kci Licensing Inc | Abdominal wound dressing |
BR0102116B1 (en) | 2000-05-10 | 2010-09-21 | component for a breathing circuit member. | |
BR0110964A (en) | 2000-05-19 | 2003-12-30 | Kimberly Clark Co | Intake Systems for Personal Care Products |
US7559324B2 (en) | 2000-06-21 | 2009-07-14 | Fisher & Paykel Healthcare Limited | Conduit with heated wick |
US20020090496A1 (en) | 2000-11-01 | 2002-07-11 | Sang-Hoon Kim | Adhesive tapes and adhesive note pads featuring non-adhesive sections |
NZ526039A (en) | 2000-11-29 | 2004-11-26 | Bristol Myers Squibb Co | A method of preparing light stabilized antimicrobial materials from an organic solvent and a source of silver |
US6855135B2 (en) | 2000-11-29 | 2005-02-15 | Hill-Rom Services, Inc. | Vacuum therapy and cleansing dressing for wounds |
US6685681B2 (en) | 2000-11-29 | 2004-02-03 | Hill-Rom Services, Inc. | Vacuum therapy and cleansing dressing for wounds |
US6541098B2 (en) | 2000-12-22 | 2003-04-01 | Avery Dennison Corporation | Three-dimensional flexible adhesive film structures |
WO2002062403A1 (en) | 2001-02-08 | 2002-08-15 | Coloplast A/S | A medical dressing comprising an antimicrobial silver compound |
CA2438505A1 (en) | 2001-02-14 | 2002-09-12 | Genzyme Corporation | Altered peptide ligands |
US7700819B2 (en) | 2001-02-16 | 2010-04-20 | Kci Licensing, Inc. | Biocompatible wound dressing |
US7070584B2 (en) | 2001-02-20 | 2006-07-04 | Kci Licensing, Inc. | Biocompatible wound dressing |
US6540705B2 (en) | 2001-02-22 | 2003-04-01 | Core Products International, Inc. | Ankle brace providing upper and lower ankle adjustment |
WO2002074030A1 (en) | 2001-03-07 | 2002-09-19 | Harman International Industries, Inc. | Sound system having a hf horn coaxially aligned in the mouth of a midrange horn |
WO2002083046A1 (en) | 2001-04-16 | 2002-10-24 | Pamela Howard | Wound dressing system |
US20020156410A1 (en) | 2001-04-19 | 2002-10-24 | Roger Lawry | Scar tissue treatment bandage and method |
US7645269B2 (en) | 2001-04-30 | 2010-01-12 | Kci Licensing, Inc. | Gradient wound treatment system and method |
ATE465707T1 (en) | 2001-07-12 | 2010-05-15 | Kci Medical Resources | CONTROL OF VACUUM CHANGE RATE |
GB2377939B (en) | 2001-07-26 | 2005-04-20 | Johnson & Johnson Medical Ltd | Apertured sheet materials |
US7004915B2 (en) | 2001-08-24 | 2006-02-28 | Kci Licensing, Inc. | Negative pressure assisted tissue treatment system |
SE524111C2 (en) | 2001-09-28 | 2004-06-29 | Jan Otto Solem | A method and device for organ recovery |
US6787682B2 (en) | 2001-11-05 | 2004-09-07 | Hollister Incorporated | Absorbent foam wound dressing |
US6648862B2 (en) | 2001-11-20 | 2003-11-18 | Spheric Products, Ltd. | Personally portable vacuum desiccator |
GB2382305B (en) | 2001-11-23 | 2004-12-15 | Johnson & Johnson Medical Ltd | Absorbent wound dressings containing a hydrogel layer |
GB2382775B (en) | 2001-12-06 | 2005-05-25 | Johnson & Johnson Medical Ltd | Controlled release therapeutic wound dressings |
DE60217925T2 (en) | 2001-12-20 | 2007-11-08 | Noble Fiber Technologies, Llc | METALLIC SILVER CONTAINING WOUND ASSOCIATIONS |
US20050143694A1 (en) | 2002-02-15 | 2005-06-30 | Schmidt Nicolai M. | Wound care device |
US6749621B2 (en) | 2002-02-21 | 2004-06-15 | Integrated Vascular Systems, Inc. | Sheath apparatus and methods for delivering a closure device |
US6693180B2 (en) | 2002-04-04 | 2004-02-17 | China Textile Institute | Composite sponge wound dressing made of β-Chitin and Chitosan and method for producing the same |
CA2481016C (en) | 2002-04-10 | 2012-04-03 | Hill-Rom Services, Inc. | Access openings in vacuum bandage |
US20030212357A1 (en) | 2002-05-10 | 2003-11-13 | Pace Edgar Alan | Method and apparatus for treating wounds with oxygen and reduced pressure |
US20030225347A1 (en) | 2002-06-03 | 2003-12-04 | Argenta Louis C. | Directed tissue growth employing reduced pressure |
US20050224978A1 (en) | 2002-06-24 | 2005-10-13 | Kohichiro Kawate | Heat curable adhesive composition, article, semiconductor apparatus and method |
US20040002676A1 (en) | 2002-06-28 | 2004-01-01 | Siegwart Kathleen Ann | Adhesive bandage having a selectively placed layer |
DE10230121A1 (en) | 2002-07-04 | 2004-02-05 | Basf Ag | Process for making discrete patterns of adhesive coatings on a substrate |
US7846141B2 (en) | 2002-09-03 | 2010-12-07 | Bluesky Medical Group Incorporated | Reduced pressure treatment system |
DE60313471T2 (en) | 2002-09-11 | 2008-01-03 | Johnson & Johnson Medical Ltd. | WOUND BRACELET WITH ANIONIC POLYSACCHARIDE COMPLEXES WITH SILVER |
GB2392836B (en) | 2002-09-11 | 2005-05-25 | Johnson & Johnson Medical Ltd | Wound dressings for the treatment of wound infection |
US6979324B2 (en) | 2002-09-13 | 2005-12-27 | Neogen Technologies, Inc. | Closed wound drainage system |
US7520872B2 (en) | 2002-09-13 | 2009-04-21 | Neogen Technologies, Inc. | Closed wound drainage system |
US7815616B2 (en) | 2002-09-16 | 2010-10-19 | Boehringer Technologies, L.P. | Device for treating a wound |
GB2393655B (en) | 2002-09-27 | 2005-08-24 | Johnson & Johnson Medical Ltd | Wound treatment device |
US7119247B2 (en) | 2002-10-22 | 2006-10-10 | George Medical, Llc | Dressing and a method for making and applying a dressing |
GB0224986D0 (en) | 2002-10-28 | 2002-12-04 | Smith & Nephew | Apparatus |
US20040219337A1 (en) | 2002-11-25 | 2004-11-04 | Kappler, Inc. | Breathable blood and viral barrier fabric |
US7612248B2 (en) | 2002-12-19 | 2009-11-03 | 3M Innovative Properties Company | Absorbent medical articles |
US6951553B2 (en) | 2002-12-31 | 2005-10-04 | Kci Licensing, Inc | Tissue closure treatment system and method with externally-applied patient interface |
US7976519B2 (en) | 2002-12-31 | 2011-07-12 | Kci Licensing, Inc. | Externally-applied patient interface system and method |
JP2006516003A (en) | 2002-12-31 | 2006-06-15 | オスール・エイチエフ | Wound dressing |
US7244251B2 (en) | 2003-02-07 | 2007-07-17 | Alfred E. Mann Institute For Biomedical Engineering | Implanted surgical drain with multiple sensing elements for monitoring internal tissue condition |
US7351217B2 (en) | 2003-05-23 | 2008-04-01 | Yvette Scherpenborg | Thermal compressive aerating bandage and methods of use relating to same |
IES20030443A2 (en) | 2003-06-16 | 2004-12-01 | Fraudhalt Ltd | A method and apparatus for determining if an optical disk originated from a valid source |
NZ543643A (en) | 2003-06-23 | 2007-09-28 | Beiersdorf Ag | Antimicrobial wound dressing with two layers and antimicrobial metal between layers but not on exterior |
US20060154546A1 (en) | 2003-06-25 | 2006-07-13 | Andover Coated Products, Inc. | Air permeable pressure-sensitive adhesive tapes |
US20050158539A1 (en) | 2003-06-25 | 2005-07-21 | Andover Coated Products, Inc. | Pressure-sensitive adhesive tapes |
US20050034731A1 (en) | 2003-08-13 | 2005-02-17 | Rousseau Robert A. | Surgical wound closure device |
US7942866B2 (en) | 2003-08-28 | 2011-05-17 | Boehringer Technologies, L.P. | Device for treating a wound |
US20050054998A1 (en) | 2003-09-05 | 2005-03-10 | Poccia John F. | Absorbent article |
US20050065484A1 (en) | 2003-09-10 | 2005-03-24 | Watson Richard L. | Wound healing apparatus with bioabsorbable material and suction tubes |
WO2005034797A2 (en) | 2003-09-17 | 2005-04-21 | Ossur Hf | Wound dressing and method for manufacturing the same |
CA2576040A1 (en) | 2003-10-21 | 2005-04-28 | Bioartificial Gel Technologies Inc. | Hydrogel-containing medical articles and methods of using and making the same |
US20060083776A1 (en) | 2003-10-27 | 2006-04-20 | Bott Richard R | Preparations for topical application and methods of delivering an active agent to a substrate |
GB0325126D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus with heat |
GB0325120D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus with actives |
JP4812630B2 (en) | 2003-12-23 | 2011-11-09 | ヘムコン メディカル テクノロジーズ, インコーポレイテッド | Tissue coating assemblies, systems and methods formed from hydrophilic polymer sponge structures such as chitosan |
JP4303143B2 (en) | 2003-12-25 | 2009-07-29 | ユニ・チャーム株式会社 | Panty liner |
US7137390B2 (en) | 2004-01-23 | 2006-11-21 | Ric Investments, Llc. | Liquid absorbing filter assembly and system using same |
US20050163978A1 (en) | 2004-01-27 | 2005-07-28 | Esben Strobech | Article having a surface showing adhesive properties |
CA2560840C (en) * | 2004-03-24 | 2014-05-06 | Corium International, Inc. | Transdermal delivery device |
US8062272B2 (en) | 2004-05-21 | 2011-11-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US7909805B2 (en) | 2004-04-05 | 2011-03-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
GB0409293D0 (en) | 2004-04-27 | 2004-06-02 | Smith & Nephew | Apparatus with flow stress |
US8529548B2 (en) | 2004-04-27 | 2013-09-10 | Smith & Nephew Plc | Wound treatment apparatus and method |
US20050277860A1 (en) | 2004-06-14 | 2005-12-15 | Jentec, Inc. | Extended stay-on wound dressing |
GB2415382A (en) | 2004-06-21 | 2005-12-28 | Johnson & Johnson Medical Ltd | Wound dressings for vacuum therapy |
DE202004017052U1 (en) | 2004-11-02 | 2005-06-09 | Riesinger, Birgit | Device for wound treatment using negative pressure |
DE202004018245U1 (en) | 2004-11-24 | 2005-07-07 | Riesinger, Birgit | Drainage device for treating wounds using reduced pressure has absorption body with layer(s) of textile section enriched with super-absorbents enclosed by liquid transmissive sleeve; absorbed wound secretions remain in absorption body |
US7161056B2 (en) | 2005-01-28 | 2007-01-09 | Ossur Hf | Wound dressing and method for manufacturing the same |
DE502006008159D1 (en) | 2005-03-24 | 2010-12-09 | Ems Chemie Ag | Use of a piping system for volatile fluids |
GB2425487A (en) | 2005-04-26 | 2006-11-01 | Dow Corning | Wound dressing and method of preparation |
US8372040B2 (en) | 2005-05-24 | 2013-02-12 | Chrono Therapeutics, Inc. | Portable drug delivery device including a detachable and replaceable administration or dosing element |
CN101257877B (en) | 2005-06-29 | 2013-07-17 | 应用纸巾技术有限公司 | Wound dressing |
US20070027414A1 (en) | 2005-07-28 | 2007-02-01 | Integra Lifesciences Corporation | Laminar construction negative pressure wound dressing including bioabsorbable material |
EP1924854B1 (en) | 2005-08-16 | 2016-04-13 | Oridion Medical 1987 Ltd. | Breath sampling device and method for using same |
US7569742B2 (en) | 2005-09-07 | 2009-08-04 | Tyco Healthcare Group Lp | Self contained wound dressing with micropump |
JP5005916B2 (en) | 2005-12-09 | 2012-08-22 | スリーエム イノベイティブ プロパティズ カンパニー | Release agent composition for skin adhesive |
DE202005019670U1 (en) | 2005-12-14 | 2006-04-27 | Riesinger, Birgit | Wound treatment device with elastically deformable negative pressure generating element |
US7622629B2 (en) | 2005-12-15 | 2009-11-24 | Aalnex, Inc. | Wound shield for exudate management |
DE202006007877U1 (en) | 2006-01-25 | 2006-07-27 | Riesinger, Birgit | Prefabricated wound dressing with superabsorber |
CA2635697A1 (en) | 2006-02-02 | 2007-08-09 | Coloplast A/S | A suction system |
RU2436597C2 (en) | 2006-02-06 | 2011-12-20 | КейСиАй ЛАЙСЕНЗИНГ, ИНК. | Methods and devices for advanced attachment of wound dressing to low-pressure wound healing systems |
JP2007254515A (en) | 2006-03-22 | 2007-10-04 | Lintec Corp | Pressure-sensitive adhesive sheet for application to skin |
GB0606661D0 (en) | 2006-04-03 | 2006-05-10 | Brightwake Ltd | Improvements relating to dressings |
DE102006017194B4 (en) | 2006-04-12 | 2010-11-04 | Birgit Riesinger | Fluid-permeable primary dressing |
BRPI0601479A (en) | 2006-05-03 | 2007-12-18 | Johnson & Johnson Ind Ltda | adhesive bandage |
US7615036B2 (en) | 2006-05-11 | 2009-11-10 | Kalypto Medical, Inc. | Device and method for wound therapy |
US7779625B2 (en) | 2006-05-11 | 2010-08-24 | Kalypto Medical, Inc. | Device and method for wound therapy |
GB2439928A (en) | 2006-07-13 | 2008-01-16 | Ethicon Inc | Hydrogel wound dressings exhibiting reduced fiber losses |
US20090326488A1 (en) | 2006-07-24 | 2009-12-31 | Klaus Budig | Canister, Suction Device and System For Vacuum Treatment Securing a Fixed Treatment Pressure |
US7504550B2 (en) | 2006-08-31 | 2009-03-17 | Kimberly-Clark Worldwide, Inc. | Conductive porous materials |
CA2964674A1 (en) | 2006-09-28 | 2008-03-28 | Smith & Nephew, Inc. | Portable wound therapy system |
DE102006047041A1 (en) | 2006-10-02 | 2008-04-10 | Birgit Riesinger | Areal absorbent body |
JP2010505517A (en) | 2006-10-03 | 2010-02-25 | アーセナル メディカル, インコーポレイテッド | Articles and methods for tissue repair |
SE0602064L (en) | 2006-10-03 | 2008-04-04 | Moelnlycke Health Care Ab | Wound dressing with pressure distributing hose inlet |
AU2007313282B2 (en) | 2006-10-13 | 2010-12-16 | Kci Licensing Inc. | Reduced pressure delivery system having a manually-activated pump for providing treatment to low-severity wounds |
SE0602303L (en) | 2006-11-01 | 2008-05-02 | Moelnlycke Health Care Ab | The operating sheet with easy bendable edge and stiffening edge layer |
DE202007019572U1 (en) | 2006-12-06 | 2013-12-02 | Weinmann Geräte für Medizin GmbH + Co. KG | Respiratory mask with a filling body |
US7674345B2 (en) | 2006-12-08 | 2010-03-09 | 3M Innovative Properties Company | Adhesive articles with discontinuities and methods of making the same |
US7740928B2 (en) | 2007-01-22 | 2010-06-22 | Building Materials Investment Corporation | Peel and stick stretch wrap |
EP3527235A1 (en) | 2007-02-09 | 2019-08-21 | KCI Licensing, Inc. | System for managing reduced pressure at a tissue site |
US8267908B2 (en) | 2007-02-09 | 2012-09-18 | Kci Licensing, Inc. | Delivery tube, system, and method for storing liquid from a tissue site |
CN101605519B (en) | 2007-02-09 | 2013-05-22 | 凯希特许有限公司 | Breathable interface system for topical pressure reducing |
WO2008104609A1 (en) | 2007-03-01 | 2008-09-04 | Coloplast A/S | Pressure-distributing elements for use with negative pressure therapy |
EP2129409B2 (en) | 2007-03-14 | 2021-11-24 | The Board of Trustees of the Leland Stanford Junior University | Devices for application of reduced pressure therapy |
US8083712B2 (en) | 2007-03-20 | 2011-12-27 | Neogen Technologies, Inc. | Flat-hose assembly for wound drainage system |
US20080269657A1 (en) | 2007-04-26 | 2008-10-30 | Isense Corporation | Adhesive overbandage |
DE102008020553A1 (en) | 2007-04-29 | 2008-10-30 | Iskia Gmbh & Co.Kg | Flat drainage for wound treatment |
AU2008262140B2 (en) | 2007-05-24 | 2014-04-24 | Applied Tissue Technologies Llc | Wound treatment device employing negative pressure |
GB0710846D0 (en) | 2007-06-06 | 2007-07-18 | Bristol Myers Squibb Co | A wound dressing |
SE531259C2 (en) | 2007-06-27 | 2009-02-03 | Moelnlycke Health Care Ab | Device for treating reduced pressure ulcers |
US20090025724A1 (en) | 2007-07-16 | 2009-01-29 | Herron Jr Roy Howard | System for removal of water from a hose and the hygroscopic hose utilized |
GB2452720A (en) | 2007-09-11 | 2009-03-18 | Ethicon Inc | Wound dressing with an antimicrobial absorbent layer and an apertured cover sheet |
US20090088719A1 (en) | 2007-09-27 | 2009-04-02 | Tyco Healthcare Retail Service Ag | Absorbent article having integral stretch panels and methods for making the same |
AU2008327660B2 (en) | 2007-11-21 | 2014-02-13 | Smith & Nephew Plc | Wound dressing |
HUE049431T2 (en) | 2007-11-21 | 2020-09-28 | Smith & Nephew | Wound dressing |
US20130096518A1 (en) | 2007-12-06 | 2013-04-18 | Smith & Nephew Plc | Wound filling apparatuses and methods |
GB2455962A (en) | 2007-12-24 | 2009-07-01 | Ethicon Inc | Reinforced adhesive backing sheet, for plaster |
US8377017B2 (en) | 2008-01-03 | 2013-02-19 | Kci Licensing, Inc. | Low-profile reduced pressure treatment system |
US8460258B2 (en) | 2008-01-08 | 2013-06-11 | Southeastern Medical Technologies, Llc | Methods and apparatuses for the treatment of wounds with pressures altered from atmospheric |
EP2244746B2 (en) | 2008-02-27 | 2019-01-02 | Aplion Medical Corporation | Wound dressing with uniform distribution |
EP2244748B1 (en) | 2008-02-27 | 2018-04-11 | KCI Licensing, Inc. | System and method for healing a wound at a tissue site |
US8449508B2 (en) | 2008-03-05 | 2013-05-28 | Kci Licensing, Inc. | Dressing and method for applying reduced pressure to and collecting and storing fluid from a tissue site |
CN104127924B (en) | 2008-03-05 | 2017-07-21 | 凯希特许有限公司 | For decompression to be applied into tissue site and the dressing and method of the fluid at collection and storage organization position |
US8021347B2 (en) | 2008-07-21 | 2011-09-20 | Tyco Healthcare Group Lp | Thin film wound dressing |
US8298200B2 (en) | 2009-06-01 | 2012-10-30 | Tyco Healthcare Group Lp | System for providing continual drainage in negative pressure wound therapy |
US20090234306A1 (en) | 2008-03-13 | 2009-09-17 | Tyco Healthcare Group Lp | Vacuum wound therapy wound dressing with variable performance zones |
CN102046121A (en) | 2008-04-04 | 2011-05-04 | 3M创新有限公司 | Wound dressing with micropump |
SE533170C2 (en) | 2008-04-09 | 2010-07-13 | Moelnlycke Health Care Ab | Device for treating wounds with suppression |
US8007481B2 (en) | 2008-07-17 | 2011-08-30 | Tyco Healthcare Group Lp | Subatmospheric pressure mechanism for wound therapy system |
US8048046B2 (en) | 2008-05-21 | 2011-11-01 | Tyco Healthcare Group Lp | Wound therapy system with housing and canister support |
US8257326B2 (en) | 2008-06-30 | 2012-09-04 | Tyco Healthcare Group Lp | Apparatus for enhancing wound healing |
US20100030549A1 (en) * | 2008-07-31 | 2010-02-04 | Lee Michael M | Mobile device having human language translation capability with positional feedback |
CN102083479A (en) | 2008-08-05 | 2011-06-01 | 莫恩里克保健公司 | Component for securing attachment of a medical device to skin |
US8251979B2 (en) | 2009-05-11 | 2012-08-28 | Tyco Healthcare Group Lp | Orientation independent canister for a negative pressure wound therapy device |
US8216198B2 (en) | 2009-01-09 | 2012-07-10 | Tyco Healthcare Group Lp | Canister for receiving wound exudate in a negative pressure therapy system |
US20110171480A1 (en) | 2008-09-16 | 2011-07-14 | Asahi Rubber Inc. | Three-dimensional silicone-rubber bonded object |
CA2740646C (en) | 2008-10-29 | 2013-07-16 | Kci Licensing, Inc. | Reduced-pressure, wound-closure and treatment systems and methods |
MX2011005075A (en) | 2008-11-14 | 2011-05-25 | Kci Licensing Inc | Fluid pouch, system, and method for storing fluid from a tissue site. |
KR20110097852A (en) | 2008-11-19 | 2011-08-31 | 케이씨아이 라이센싱 인코포레이티드 | Dynamic, reduced-pressure treatment systems and methods |
GB0821702D0 (en) | 2008-11-28 | 2008-12-31 | Brightwake Ltd | Process |
US8162907B2 (en) | 2009-01-20 | 2012-04-24 | Tyco Healthcare Group Lp | Method and apparatus for bridging from a dressing in negative pressure wound therapy |
US9067035B2 (en) | 2009-03-03 | 2015-06-30 | Oridion Medical (1987) Ltd. | Drying substances, preparation and use thereof |
JP5706882B2 (en) | 2009-04-17 | 2015-04-22 | スリーエム イノベイティブ プロパティズ カンパニー | Silicone gel adhesive composition |
WO2010122665A1 (en) | 2009-04-24 | 2010-10-28 | アルケア株式会社 | Wound-care product and method for producing the same |
EP2424948B1 (en) | 2009-04-27 | 2017-03-22 | Avery Dennison Corporation | Releasable adhesive having a multilayer substrate |
US20100324516A1 (en) | 2009-06-18 | 2010-12-23 | Tyco Healthcare Group Lp | Apparatus for Vacuum Bridging and/or Exudate Collection |
US8469936B2 (en) | 2009-07-15 | 2013-06-25 | Kci Licensing, Inc. | Reduced-pressure dressings, systems, and methods employing desolidifying barrier layers |
EP2477559A4 (en) | 2009-09-17 | 2015-05-27 | Zipline Medical Inc | Rapid closing surgical closure device |
US8529526B2 (en) | 2009-10-20 | 2013-09-10 | Kci Licensing, Inc. | Dressing reduced-pressure indicators, systems, and methods |
US8721606B2 (en) | 2010-03-11 | 2014-05-13 | Kci Licensing, Inc. | Dressings, systems, and methods for treating a tissue site |
US8814842B2 (en) | 2010-03-16 | 2014-08-26 | Kci Licensing, Inc. | Delivery-and-fluid-storage bridges for use with reduced-pressure systems |
US20110257617A1 (en) | 2010-04-02 | 2011-10-20 | Franklin Amie B | Therapeutic Diffusion Hydrocolloid Wound Dressings |
ES2634551T3 (en) | 2010-04-03 | 2017-09-28 | Praful Doshi | Methods for coating a contact lens |
DE102010014010A1 (en) | 2010-04-03 | 2011-10-06 | Birgit Riesinger | Wound care article adapted to different flow rates of the wound exudate |
US8702665B2 (en) | 2010-04-16 | 2014-04-22 | Kci Licensing, Inc. | Reduced-pressure sources, systems, and methods employing a polymeric, porous, hydrophobic material |
US9061095B2 (en) | 2010-04-27 | 2015-06-23 | Smith & Nephew Plc | Wound dressing and method of use |
JP5180410B2 (en) | 2010-06-01 | 2013-04-10 | 株式会社瑞光 | Top sheet for wound dressing and wound dressing |
WO2011162862A1 (en) | 2010-06-23 | 2011-12-29 | Convatec Technologies Inc. | Wound dressing |
US9265665B2 (en) | 2010-07-19 | 2016-02-23 | Kci Licensing, Inc. | Inflatable off-loading wound dressing assemblies, systems, and methods |
US20120019031A1 (en) | 2010-07-21 | 2012-01-26 | Gregory Robert Bessert | Wheelchair Cover |
US20120040131A1 (en) | 2010-08-10 | 2012-02-16 | Speer Dwaine D | Composite Panel Having Perforated Foam Core |
US8986269B2 (en) | 2010-11-11 | 2015-03-24 | Ulcerx Medical Inc. | Wound leakage vacuum collection device |
GB2488749A (en) | 2011-01-31 | 2012-09-12 | Systagenix Wound Man Ip Co Bv | Laminated silicone coated wound dressing |
US9107990B2 (en) | 2011-02-14 | 2015-08-18 | Kci Licensing, Inc. | Reduced-pressure dressings, systems, and methods for use with linear wounds |
US20120258271A1 (en) | 2011-04-08 | 2012-10-11 | Pointil Systems Inc. | Methods for reducing tack of pressure-sensitive adhesive |
WO2012142001A1 (en) * | 2011-04-12 | 2012-10-18 | Kci Licensing, Inc. | Reduced-pressure interfaces, systems, and methods employing a coanda device |
GB201106491D0 (en) | 2011-04-15 | 2011-06-01 | Systagenix Wound Man Ip Co Bv | Patterened silicone coating |
FR2974005B1 (en) | 2011-04-15 | 2014-05-02 | Urgo Lab | THIN ABSORBENT THIN ADHESIVE DRESSING, ITS USES FOR THE TREATMENT OF CHRONIC WOUNDS |
EP2699276B1 (en) | 2011-04-21 | 2016-08-03 | Smith & Nephew PLC | Blockage management |
GB201108229D0 (en) | 2011-05-17 | 2011-06-29 | Smith & Nephew | Tissue healing |
WO2013009239A1 (en) | 2011-07-08 | 2013-01-17 | Mölnlycke Health Care Ab | Self-adhesive wound care product |
RU2014104355A (en) | 2011-07-08 | 2015-08-20 | Контра Вижн Лтд. | OPEN PERFORATED MATERIAL AND METHOD FOR FORMING THE IMAGE FOR FORMING A CONTROLLED VISIBILITY PANEL |
AU2012287136B2 (en) | 2011-07-26 | 2016-11-17 | Solventum Intellectual Properties Company | Systems and methods for treating a tissue site with reduced pressure involving a reduced-pressure interface having a multi-lumen conduit for contacting a manifold |
EP2561844B1 (en) | 2011-08-23 | 2016-01-20 | Zodiac Coating | Verbundmaterial, das eine textile Wirkwarenunterlage umfasst |
WO2013039622A2 (en) | 2011-09-14 | 2013-03-21 | Kci Licensing, Inc. | Reduced-pressure systems and methods employing a leak-detection member |
EP3296436B1 (en) | 2011-11-01 | 2019-07-24 | Brightwake Limited | Wound dressings, and fabric useful therein |
US9192444B2 (en) | 2011-12-16 | 2015-11-24 | Kci Licensing, Inc. | Sealing systems and methods employing a switchable drape |
EP3005997B1 (en) | 2011-12-16 | 2024-06-26 | Solventum Intellectual Properties Company | Releasable medical drapes |
CN109125789B (en) | 2012-03-12 | 2022-05-10 | 博斯蒂克股份公司 | Adhesive composition, breathable self-adhesive article, use of self-adhesive article and method for producing same |
US10286129B2 (en) * | 2012-03-28 | 2019-05-14 | Kci Licensing, Inc. | Reduced-pressure systems, dressings, and methods facilitating separation of electronic and clinical component parts |
CN107095739B (en) | 2012-05-23 | 2020-11-13 | 史密夫及内修公开有限公司 | Apparatus and method for negative pressure wound therapy |
WO2014022400A1 (en) | 2012-07-30 | 2014-02-06 | Kci Licensing, Inc. | Reduced-pressure absorbent dressing, system for treating a tissue site, and method of manufacturing the dressing |
CA3178997A1 (en) | 2012-08-01 | 2014-02-06 | Smith & Nephew Plc | Wound dressing |
WO2014022548A1 (en) * | 2012-08-03 | 2014-02-06 | Kci Licensing, Inc. | Interfaces, systems, and methods for use in reduced pressure tissue treatment |
WO2014039557A1 (en) | 2012-09-04 | 2014-03-13 | Integrated Healing Technologies | Wound dressing |
CN111991092A (en) | 2012-11-16 | 2020-11-27 | 凯希特许有限公司 | Medical drape having patterned adhesive layer and method of making same |
DE102013100157A1 (en) | 2013-01-09 | 2014-07-10 | Birgit Riesinger | Liquid-permeable primary dressing with a silicone coating |
JP6392781B2 (en) | 2013-01-16 | 2018-09-19 | ケーシーアイ ライセンシング インコーポレイテッド | Dressing with asymmetric absorbent core for negative pressure closure therapy |
EP4018985A1 (en) | 2013-03-14 | 2022-06-29 | 3M Innovative Properties Co. | Absorbent dressing with hybrid drape |
BR112015020855A2 (en) | 2013-03-15 | 2017-07-18 | Smith & Nephew | wound dressing and treatment method |
JP6808323B2 (en) | 2013-03-15 | 2021-01-06 | スミス アンド ネフュー ピーエルシーSmith & Nephew Public Limited Company | Wound dressing sealant and its use |
GB2512841B (en) | 2013-04-08 | 2020-07-15 | Brightwake Ltd | Absorbent wound dressings |
US20140352073A1 (en) | 2013-06-04 | 2014-12-04 | Welspun India Limited | Semi-absorbent, semi-resistant, breathable fabric |
WO2015065615A1 (en) * | 2013-10-30 | 2015-05-07 | Kci Licensing, Inc. | Absorbent conduit and system |
US9956120B2 (en) * | 2013-10-30 | 2018-05-01 | Kci Licensing, Inc. | Dressing with sealing and retention interface |
TR201807060T4 (en) | 2013-10-30 | 2018-06-21 | Kci Licensing Inc | Winding with different sizes of perforations. |
DE202014100383U1 (en) | 2014-01-29 | 2015-02-02 | Birgit Riesinger | Wound care article comprising a material with high restoring force |
CA2940730C (en) | 2014-02-28 | 2022-07-26 | Kci Licensing, Inc. | Hybrid drape having a gel-coated perforated mesh |
WO2017048866A1 (en) | 2015-09-17 | 2017-03-23 | Kci Licensing, Inc. | Hybrid silicone and acrylic adhesive cover for use with wound treatment |
-
2015
- 2015-05-04 US US15/307,472 patent/US10406266B2/en active Active
- 2015-05-04 EP EP15725449.1A patent/EP3137029B1/en active Active
- 2015-05-04 WO PCT/US2015/029037 patent/WO2015168681A1/en active Application Filing
-
2019
- 2019-07-31 US US16/528,441 patent/US20190351111A1/en not_active Abandoned
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11628093B2 (en) | 2008-05-08 | 2023-04-18 | Convatec Technologies, Inc. | Wound dressing |
US11458044B2 (en) | 2008-09-29 | 2022-10-04 | Convatec Technologies Inc. | Wound dressing |
US11135315B2 (en) | 2010-11-30 | 2021-10-05 | Convatec Technologies Inc. | Composition for detecting biofilms on viable tissues |
US11241525B2 (en) | 2010-12-08 | 2022-02-08 | Convatec Technologies Inc. | Wound exudate monitor accessory |
US11116884B2 (en) | 2010-12-08 | 2021-09-14 | Convatec Technologies Inc. | Integrated system for assessing wound exudates |
US11583430B2 (en) | 2011-09-02 | 2023-02-21 | Convatec Ltd. | Skin contact material |
US11241339B2 (en) | 2011-11-29 | 2022-02-08 | Convatec Inc. | Perforated binder for laminated wound dressing |
US10968543B2 (en) | 2011-12-01 | 2021-04-06 | Convatec Technologies Inc. | Wound dressing for use in vacuum therapy |
US11286601B2 (en) | 2012-12-20 | 2022-03-29 | Convatec Technologies, Inc. | Processing of chemically modified cellulosic fibres |
US11723808B2 (en) | 2016-03-30 | 2023-08-15 | Convatec Technologies Inc. | Detecting microbial infections in wounds |
US11740241B2 (en) | 2016-03-30 | 2023-08-29 | Synovo Gmbh | Construct including an anchor, an enzyme recognition site and an indicator region for detecting microbial infection in wounds |
US11266774B2 (en) | 2016-07-08 | 2022-03-08 | Convatec Technologies Inc. | Fluid collection apparatus |
US11452808B2 (en) | 2016-07-08 | 2022-09-27 | Convatec Technologies Inc. | Fluid flow sensing |
US11596554B2 (en) | 2016-07-08 | 2023-03-07 | Convatec Technologies Inc. | Flexible negative pressure system |
US11331221B2 (en) | 2019-12-27 | 2022-05-17 | Convatec Limited | Negative pressure wound dressing |
US11771819B2 (en) | 2019-12-27 | 2023-10-03 | Convatec Limited | Low profile filter devices suitable for use in negative pressure wound therapy systems |
Also Published As
Publication number | Publication date |
---|---|
EP3137029A1 (en) | 2017-03-08 |
WO2015168681A1 (en) | 2015-11-05 |
EP3137029B1 (en) | 2020-09-09 |
US10406266B2 (en) | 2019-09-10 |
US20170043070A1 (en) | 2017-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20190351111A1 (en) | Fluid storage devices, systems, and methods | |
US11964095B2 (en) | Condensate absorbing and dissipating system | |
US20240000615A1 (en) | Dressing with sealing and retention interface | |
US20210162105A1 (en) | Dressing with differentially sized perforations | |
US10849792B2 (en) | Absorbent conduit and system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: KCI LICENSING, INC., TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LOCKE, CHRISTOPHER BRIAN;ROBINSON, TIMOTHY MARK;SIGNING DATES FROM 20190627 TO 20190628;REEL/FRAME:052504/0244 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |